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Neisseria gonorrhoeae is an important human pathogen which causes 
significant worldwide morbidity. The effects of two important neisserial surface 
molecules, LOS and H.8, as well as initial bacterial challenge dose, upon the 
interactions of N. gonorrhoeae with human monocytes and macrophages, were 
examined in this study. The data presented here demonstrate that alterations in the 
carbohydrate moiety of LOS do not directly impact production of proinflammatory 
cytokines. However, when specific LOS mutants were sialylated, upregulation of the 
chemokine MCP-2 was observed. The H.8 antigen was demonstrated to have little 
effect on monocytic cytokine production, but does appear to play a significant role 
during physical interactions with macrophages. In comparison with the parent strain, 
a greater percentage of the H.8- bacterial challenge population was shown to form 
large aggregates upon contact with human macrophages, and appeared to resist 
phagocytosis. I propose that host recognition of gonococcal surface structures, such 
  
as H.8 and sialylated LOS, may promote elicitation of monocytes and phagocytosis of 
the bacteria. This may contribute to gonococcal intracellular growth, and result in 
chronic and disseminated infection.  
Finally, the experiments described here demonstrate the significance of 
bacterial dose during gonococcal challenge. While a high MOI was shown to cause 
elicitation of many proinflammatory cytokines and chemokines, a low MOI elicited a 
strong chemokine response in the absence of significant TNFα production. As the 
cytokine TNFα is thought to lead to tissue damage caused during gonococcal 
infection, these data may help to explain asymptomatic gonorrhea. Induction of IL-8 
expression in low MOI challenges was produced independent of TNFα or IL-1β, and 
required NF-κB activation, though this activation was limited by the inoculating dose. 
Analysis of various MAP kinases indicated that low MOI challenges were able to 
efficiently activate both the ERK and p38 pathways, but failed to activate the JNK 
pathway. A lack of phosphorylated JNK leads to decreased production of AP-1 
dimers, transcription factors that are critical for efficient transcription of TNFα. I 
therefore propose a mechanism where a low MOI gonococcal challenge results in 
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Background and Significance 
 The genus Neisseria includes primarily commensal organisms which colonize 
the mucous membranes of mammals (1). These organisms are aerobic, Gram negative 
cocci, usually arranged in pairs (diplococci). Though several Neisseria species 
occasionally cause opportunistic infections in immunocompromised hosts, two 
species, Neisseria gonorrhoeae and N. meningitidis, can cause significant disease.  
While N. meningitidis typically colonizes the nasopharynx of infected 
individuals, it often does not cause disease. It has been estimated that this organism is 
asymptomatically carried by up to 25% of a population, where only a few individuals 
develop invasive infections (2). However, N. meningitidis can spread to the 
bloodstream, causing septicemia, and cross the blood-brain barrier where it induces 
meningitis. The principal means of transmission of N. meningitidis is through 
respiratory droplets of an infected individual (3). N. gonorrhoeae however, is the only 
obligate pathogen of the Neisseriaceae and is the causative agent of the sexually 
transmitted disease gonorrhea. This disease classically manifests as a local infection 
of the columnar epithelial cells of the mucosa (i.e. urethra, cervix, rectum) and is 
primarily transmitted through sexual contact. Occasionally, this organism causes 
ocular infections in neonates who acquire it upon passage through an infected birth 
canal (4, 5).  
Gonorrhea is described by the U.S. Centers for Disease Control (CDC) as the 




2004). Over 300,000 cases of gonorrhea were reported to the CDC in 2004, though 
this number likely underrepresents actual disease occurrence due to the prevalence of 
asymptomatic infections. Gonococcal infections lead to a significant worldwide 
public health burden which is complicated by increasing antibiotic resistance. The 
CDC reports that greater than 15% of isolates collected in 2004 from STD clinics by 
the Gonococcal Isolate Surveillance Project (GISP) were resistant to penicillin, 
tetracycline, or both (CDC, 2004). This situation results has significant financial 
implications regarding treatment of the disease. 
Beyond the economic burden caused by N. gonorrhoeae, there exists an array 
of potential disease symptoms and sequelae that can be life-altering for the host. The 
severity of symptoms due to gonorrhea is strikingly different depending upon host 
gender. Disease in men is normally characterized by a massive infiltrate of 
polymorphonuclear leukocytes (PMNs, neutrophils) and monocytes to the site of 
infection, which results in pain and purulent discharge (6, 7). However, almost 80% 
of infections in women occur without noticeable symptoms (8). The reason for this 
gender-based discrepancy is unknown and individuals with asymptomatic gonorrhea 
often harbor infections which persist at subclinical levels. This is presumably 
advantageous for the bacterium, allowing continued transmission to other hosts. 
Prolonged gonococcal infections in women can lead to ascending infection and 
serious sequelae, such as pelvic inflammatory disease (PID) and disseminated 
gonococcal disease (DGI). 
PID is an upper genital tract infection involving inflammation, and is often 




fallopian tubes, ovaries, and/or adjacent structures (9). The incidence of PID is 
difficult to estimate since it is not a reportable disease, it is treated in many different 
settings, and methods for its diagnosis are inconsistent. However, when considering 
reported hospitalizations, office visits, Emergency Department visits, and women 
who do not seek care, the number of individuals affected by PID is estimated to be at 
least one million per year (10). One study suggests that approximately one out of 
every ten women suffers from PID (11). N. gonorrhoeae is often isolated from the 
cervices and fallopian tubes of women experiencing this complication, though smaller 
numbers of organisms reach the fallopian tubes, making culture of bacteria from these 
sites difficult (9). The tissue damage resulting from PID is thought to be caused by 
the proinflammatory cytokine tumor necrosis factor alpha (TNFα) (12), and this 
damage can predispose women to ectopic pregnancy or fallopian tube scarring and 
subsequent sterility [for review see (13)]. The pathology that mediates this infertility 
is caused by acute and chronic inflammation. Evidence of intraluminal exudates, 
microabscesses, and neutrophil/ monocyte infiltration can be seen upon microscopic 
examination of the fallopian tube tissue (9).  
  DGI is estimated to occur in 0.5-3% of Americans infected with gonorrhea 
each year (14). This condition is often characterized by dermatitis, tenosynovitis, and 
migratory polyarthritis. Diagnosis of DGI, as for other disease sequelae, is 
complicated by the frequency of asymptomatic gonococcal infections. The lack of 
symptoms from these silent infections provides no clues as to the disease etiology. 
Without prompt diagnosis and treatment, endocarditis, meningitis, perihepatitis and 




 Aside from the direct complications associated with gonorrhea, recent work 
has indicated a correlation between gonococcal infection and increased transmission 
of the human immunodeficiency virus (HIV) (15-18). Gonococci are known to 
increase local expression of viral RNA and cause an intense inflammatory response, 
leading to a loss of mucosal integrity. Both of these disease characteristics increase 
susceptibility to HIV type 1 (15). 
 
Human Innate & Adaptive Immunity 
The mucosal tissues of the urogenital tract serve as the host’s initial line of 
defense against sexually transmitted pathogens such as N. gonorrhoeae. Epithelial 
cells connected by tight junctions provide an integral barrier function against 
invading microbes. These cells can produce a variety of antimicrobials including 
defensins, complement, cytokines, and immunoglobulin. [for review see (19)].  
The complement system, involving interaction of serum and cell surface proteins with 
either microbial cell surfaces (alternative pathway) or antibodies bound to antigens 
(classical pathway) is often activated during these initial stages of invasion (20). 
Colonization or invasion of the epithelia signals response by a network of immune 
effector cells including macrophages, dendritic cells, monocytes, neutrophils, and T 
and B lymphocytes. Cutaneous immune surveillance by these cells is of central 
importance to the host’s innate response to microbial infection. These effectors have 
the ability to release antimicrobial peptides, chemokines, and cytokines in order to 




during each of these interactions initiates a variety of innate and adaptive immune 
responses.   
The innate immune response occurs upon initial recognition, by host cells, of 
several highly conserved structures found on microorganisms (22). These structures 
are termed pathogen-associated molecular patterns (PAMPs), and the cells of the 
immune system have evolved to recognize them through pattern-recognition receptors 
(PRRs). As PAMPs are made only by microbial pathogens, detection of these via 
highly specific receptors allows the host to differentiate between its own surface 
molecules and those of an invading microorganism. In addition, PAMPs are usually 
invariant and necessary for the survival of the pathogen, increasing the likelihood that 
host PRRs will remain effective over time (22). The PRRs of the immune system are 
encoded into the germ line and are expressed on many effector cells such as 
macrophages, dendritic cells, and B cells (22). There are three main functional classes 
of mammalian PRRs: secreted PRRs (e.g. mannan binding lectin), endocytic PRRs 
(e.g. the macrophage mannose receptor), and signaling PRRs [e.g. toll-like receptors 
(TLRs)]. These receptors play a major role in, respectively, opsonization of invading 
microbes, phagocytosis and killing of these microbes, and induction of the 
inflammatory response. PRRs allow for a very rapid host response to infection, which 
precedes the action of the adaptive immune response (22). 
  After initial recognition of a pathogen by the innate immune system, the 
adaptive immune system can respond in a variety of ways. The cell-mediated 
response occurs as a result of T lymphocytes which can help to destroy microbes 




response, via specific antibodies, is generated by B lymphocytes (23). An important 
distinction between the innate and adaptive immune systems is that adaptive immune 
receptors (found on T cells and B cells) are generated somatically. This system results 
in a structurally unique receptor on the surface of each lymphocyte (22). These 
receptors are generated randomly and are not specific for any particular antigen. 
Those that are effective during infection (i.e. bind specifically to a pathogen) are 
selected for clonal expansion (22). Therefore the adaptive immune response requires 
cell proliferation after recognition of an antigen. This system results in an array of 
receptors which serve to protect the host from virtually any pathogen and allows the 
host a means to develop “memory” of past microbe encounters.   
 
Inflammation and Cytokines 
Cytokines, often called interleukins (IL), are proteins which are produced by 
cells involved in host innate and adaptive immune responses. Production of these 
proteins occurs quickly in response to pathogens, serving to elicit an effective host 
response. Therefore, cytokine production is critical for efficient microbial clearing. 
These proteins can act in concert or alternately, one cytokine may have many 
functions. They can also promote the synthesis of other cytokines, thus sparking 
various signaling cascades, and can act both locally and systemically (23).  
Some of the most studied cytokines are those involved in inflammation. They 
can act to either induce (proinflammatory) or suppress (anti-inflammatory) 
inflammation. These cytokines are commonly produced by epithelial cells and 




interleukin-1 beta (IL-1β), interleukin-12 (IL-12), interleukin-10 (IL-10), and a 
variety of chemotactic cytokines (chemokines) such as interleukin-8 (IL-8). TNFα 
and IL-1β are two of the first cytokines produced in response to invading bacteria, 
and can act synergistically. Their production is induced by a variety of bacterial 
PAMPs including endotoxin [for review see (24, 25)]. IL-12 is an important inducer 
of cell-mediated immunity and serves to stimulate natural killer cells and T 
lymphocytes [for review see (26)]. Anti-inflammatory cytokines, such as IL-10, act to 
suppress the cascade of cellular events initiated by cytokines such as TNFα and IL-
1β. In addition, this cytokine inhibits further production of several proinflammatory 
cytokines and chemokines. Anti-inflammatory cytokines are therefore extremely 
important during the resolution of disease as the system returns to homeostasis. [for 
review see (23, 27)].  
Chemokines are small cytokines characterized by four conserved cysteines, 
linked by disulfide bonds. The positioning of the first two cysteines, either adjacent or 
separated by one amino acid, is used to classify chemokines into the CC or CXC 
subfamilies (28). Chemokines are known to be produced by leukocytes as well as 
epithelial cells, endothelial cells, and fibroblasts (23). Chemokines bind to seven-
transmembrane domain receptors and signal through heterotrimeric GTP-binding 
proteins (28). The best-characterized signal transduction pathway initiated by binding 
to this type of receptor involves activation of phospholipase C (PLC) which results in 
hydrolysis of phosphatidylinositol 4,5-bisphophate (PIP2). This process generates the 
second messengers 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). IP3 stimulates 




(PKC). Ultimately, this process leads to activation of the nuclear factor kappa B (NF-
κB)  family of transcription factors (23, 29).  
A variety of chemokines are noted for their roles during bacterial infection, 
most notably IL-8. This chemokine is secreted by epithelial cells challenged with 
bacteria, such as E. coli, and has been shown to induce massive neutrophil migration 
in vitro (30, 31). IL-8 is also known to promote neutrophil exocytosis and induce the 
respiratory burst (32). Chemokines are therefore critical in promoting clearance of 
infectious bacteria by immune effector cells.   
Several groups have investigated the production of cytokines during 
gonococcal challenge. One male challenge study using gonococcal strain MS11 found 
an increase in IL-8, IL-6 and TNFα levels in the urine samples of volunteers prior to 
the onset of symptoms. These cytokines were shown to increase concomitantly with 
the number of leukocytes found in urine sediment. At the onset of symptoms, IL-1β 
was detected (33). Fichorova, et al. measured IL-6, IL-8, and IL-1β production from 
challenged immortalized human cervical and vaginal epithelial cells using an MOI of 
100:1, and also found that IL-1β was produced later than IL-6 and IL-8.  However, 
TNFα was not measurable in these samples (34). Using a cervical epithelial cell line 
(ME180) as a model of infection, and a challenge dose of 5:1 (MOI), Naumann and 
coworkers demonstrated production of TNFα and IL-8 by 6 hours post infection (35). 
Though these experiments allow some prediction regarding cytokine production 
during gonorrhea, there is wide variety in the models, gonococcal strains, and 




Host inflammatory cascades are typically the first to be activated by bacterial 
or viral infections, and account for many aspects of disease symptoms. The current 
understanding of inflammatory processes is that mucosal inflammation can be 
triggered by epithelial cells after initial contact with a pathogen, or by more 
specialized cells once a pathogen has crossed the epithelial surface (36). After 
bacteria cross the epithelial layer, they interact with specialized cells, such as 
macrophages, and the inflammatory response is upregulated. A secondary response 
from the epithelial cells is then initiated (36). Within the subepithelial compartment a 
cytokine network is formed between responding epithelial cells, cells residing in the 
subepithelium, and those cells recruited to the site of infection (36). 
 
Manipulation of Innate Immunity by Bacterial Pathogens 
Innate immunity is not sufficient for the prevention of all infections, since 
bacterial pathogens have evolved many mechanisms for evasion of host defenses. 
Bacteria are known to use a range of complex surface molecules to enhance their 
survival and replication within the human host. These molecules can cause a variety 
of results from altering host cell cytokine production and phagocytic ability to 
interfering with immune surveillance and innate signaling pathways.   
Disruption or manipulation of normal host inflammatory cytokine production 
is a common strategy of bacterial pathogens, though the mechanisms are not always 
clear (37). Protein A from Staphylococcus aureus has been shown to bind directly to 
the TNFα receptor on respiratory epithelial cells, which elevates the cytokine 




cause immunosuppression via a virulence antigen (LcrV) which causes induction of 
IL-10 (39). Mycobacterium tuberculosis invades host macrophages and 
downregulates production of IL-12, thereby suppressing the immune response (40). 
Another study has demonstrated that TNFα induction directly supports the growth of 
M. tuberculosis within host alveolar macrophages (41). Several cytokines including 
IL-1 and TNFα have been shown to stimulate replication of HIV-1 and contribute to 
its pathogenesis (42, 43). In addition, IL-10 can increase HIV-1 replication in the 
presence of TNFα (44). It has also been demonstrated that the parasite Leishmania 
can decrease host production of TNFα and IL-12, while inducing dramatic production 
of IL-10, thereby promoting survival of the parasite in host macrophages (45). 
Whatever the mechanism, alterations in cytokine production can lead to an 
inappropriate immune response to invading pathogens, and can be devastating to the 
host. 
Many species of bacteria have developed ways in which to avoid detection by 
immune cells or subvert the actions of phagocytes (46). Production of a carbohydrate 
capsule is one way that organisms such as Streptococcus pneumoniae and N. 
meningitidis evade phagocytes. Capsules can prevent antibody and complement 
deposition, thus allowing the pathogen to escape opsonization and detection (47). 
Other bacterial pathogens, such as Yersinia species, secrete effector molecules that 
dampen host phagocytic ability (48). This mechanism allows avoidance of 
internalization by host phagocytes. However, bacteria that are readily phagocytosed 
have evolved ways in which to avoid intracellular killing once they are inside host 




phagolysosomes, and most employ methods to inhibit phagosome-lysosome fusion 
(49).  
Several pathogens secrete molecules that interfere with inflammatory 
signaling pathways. Two common targets of these pathogens are the NF-κB and 
mitogen activated protein (MAP) kinase signaling molecules (47). Bacillus anthracis 
produces a toxin which cleaves a MAP kinase and leads to blocked activation of 
genes downstream of NF-κB (50). Shigella flexneri produces an effector molecule, 
OspG, which has been shown to decrease NF-κB activation, thereby causing a 
decrease in inflammation (51). Modulation of TLR signaling is also an effective 
strategy for disruption of inflammation (39, 52). Salmonella species can modify their 
lipid A structures to decrease recognition by TLR2 and TLR4 (47). 
Gonococcal Pathogenesis 
Gonococcal pathogenesis is a complicated process which is only partially 
understood. Tissue culture models of infection and male clinical challenge studies 
have helped to elucidate the mechanisms of gonococcal infection, as no animal model 
has been widely accepted. Several gonococcal PAMPs on the bacterial cell surface 
have been characterized and may play important roles in gonococcal invasion and 
disease progression.  
Gonococci routinely exhibit phase variation of several important surface 
molecules including pili, colony opacity-associated proteins (Opas), and 
lipooligosaccharide (LOS) (Figure 1). This variation in surface expression is highly 
regulated though several genetic mechanisms and appears to assist the organisms in 








Figure 1: Illustration of the gonococcal cell surface. 
Illustration of the gonococcal cell surface. Shown are several important surface-






to the mucosal epithelial lining of the genital tract, they utilize type IV pili, which 
allow for bacterial attachment to host secretory epithelial cells (53). The cell-surface 
protein CD46 has been shown to act as a pilus receptor on host cells during 
gonococcal challenge (54). Antigenic variation in pilin sequences has been shown to 
cause cell-type-specific adherence and possibly cell tropism in vitro (55). It has been 
observed that between 8 and 16 hours post infection, gonococci appear to lose their 
pili as they bind tightly to host cell plasma membranes (53)). At this point in 
infection, classical “zippering” phagocytosis has been shown to occur (56). 
Subsequently, gonococci have been observed to survive within epithelial cells, and 
eventually traverse to the stromal matrix (57) (Figure 2).  
Another important gonococcal surface structure is the Opa protein. A single 
gonococcal strain encodes up to eleven different opa alleles. Expression of each of 
these genes is independently phase-variable and Opa heterogeneity is common. In 
relation to gonococcal disease, it has been observed that clinical samples of purulent 
discharge (due to symptomatic infection) are mainly comprised of Opa+ bacteria. 
Also, in clinical trials where individuals were inoculated with Opa- bacteria and 
allowed to develop symptoms, discharge was shown to contain almost entirely Opa+  
bacteria (58). These observations first led to the assumption that Opa proteins (and 
Opa phase variation) have a definite role in virulence. In the gonococcal strain MS11, 
Opa proteins have been shown to bind to two types of host cells receptors: the heparin 
sulfate proteoglycan (HSPG) receptors and the carcinoembryonic antigen-related 
cellular adhesion molecule (CEACAM) receptor family (59). Recently Boulton, et al. 







Figure 2: Model of gonococcal colonization of host tissues.  
Schematic diagram illustrating the sequential interactions of N. gonorrhoeae and host 
cells: adherence, intimate contact, transcytosis, and interactions with professional 




CD4+ T lymphocytes. This receptor contains an immunoreceptor tyrosine inhibition 
motif (ITIM) and provides a possible mechanism by which gonococci may suppress T 
cell activation, thus evading the host immune response via Opa variation (8). 
However, CEACAM binding does not appear necessary for the selection of Opa+ 
variants during the early stages of infection (60). In addition, Song, et al. have 
demonstrated the Opa-independent invasion of polarized epithelial cells, indicating 
only a partial role for this molecule in gonococcal pathogenesis (61). 
Lipopolysaccharides (LPS) constitute a family of toxic glycolipids which are 
integral in the outer membranes of Gram-negative organisms. These glycolipids are 
critical for the integrity and functioning of the outer membrane (62). They are also 
important surface antigens and are known to be highly immunostimulatory. Systemic 
distribution of LPS/LOS can lead to endotoxic shock (63). In addition, variation in 
LPS structure has been shown to affect bacterial virulence (64). The general structure 
of LPS is as follows: the highly hydrophobic Lipid A, a covalently attached core 
region (which can be divided into an inner and outer core), and finally a polymer of 
repeating saccharide subunits (Figure 3). This O-polysaccharide portion of the 
molecule, however, is not ubiquitous. Several Gram-negative strains, such as the 
gonococcus, express LPS with a truncated, non-repeating oligosaccharide chain, 
called LOS (65). The gonococcus routinely exhibits phase variation of its LOS which 
results in rapid and reversible alterations in oligosaccharide structure (66). A single 
strain of N. gonorrhoeae (and even a single gonococcal cell) can express several LOS 
structures at any given time (67). LOS from different strains shows antigenic 






Figure 3: Schematic representation of the structure of LOS from N. gonorrhoeae 
strain F62. 
LOS biosynthesis genes are indicated by italics. Dotted lines indicate alternative LOS 
structures. Asterisks (*) indicate possible site of PEA or phosphate attachment. The 
broken line indicates the addition of an alternate α chain, joined to HepI as a β1-4 





pathway and results in structurally identical molecules (68). Antigenic differences 
between LOS molecules from different strains can result from substitutions in various 
glycose units, alterations in sugar-sugar linkages, and additional decorations of the 
sugar backbone (69). The oligosaccharide extensions of some LOS species appear 
structurally and antigenically similar to human glycolipids, implying a role in 
molecular mimicry (70, 71). When lacto-N-neotetraose is expressed as the terminal 
tetrasaccharide, the resulting structure is identical to the carbohydrate portion of 
human paragloboside. Paragloboside is the precursor of the glycolipid antigens of 
erythrocytes in the human body (72). Other forms of LOS terminate in carbohydrates 
which match structures such as the precursor of lacto-N-neotetraose, the human pk 
glycosphingolipid, and the X2 glycosphingolipid (73). In the same way as 
paragloboside, gonococcal LOS containing the terminal lacto-N-neotetraose has been 
shown to be readily sialylated in vivo. Gonococci use host-derived cytidine 5'–
monophospho-N-acetylneuraminic acid (CMP-NANA), and their own 
sialyltransferase to add sialic acid to the terminal galactose of this LOS structure (74, 
75). The resultant sialylated LOS has been shown to protect the bacterium from 
complement-mediated killing (76, 77).  
 Porins are the most abundant Neisserial outer membrane proteins. They 
function as channels to allow diffusion of small solutes between the bacteria and their 
environment (78). Most Neisseria only express one type of porin. The gonococcus 
has two different Por-encoding genes: porA and porB, though it expresses only alleles 
of PorB (79). These proteins have been shown to play a role in Neisserial 




actin polymerization, degranulation, opsonin receptor expression, and phagocytosis, 
yet primed neutrophils to increase their oxidative burst (80). In a urethral epithelial 
cell model, gonococcal porin has been shown to increase transcription of several 
antiapoptotic factors in an NF-κB-dependent manner (81). Another study suggests 
that gonococcal porin may increase invasion of the bacteria into epithelial cells and 
inhibit the response of phagocytes (82).  
Another abundant neisserial surface molecule is the H.8 antigen (or Lip). 
Little is known about this lipoprotein other than it is conserved among the pathogenic 
Neisseria (83-85). H.8 has been shown to have unusual electrophoretic mobility, due 
to its complex nature (84, 85). It comprises 11-20 tandemly repeated pentameric 
sequences (AAEAP), a lipid-modified N-terminal cysteine residue, and lacks any 
aromatic residues (86, 87). These properties make H.8 difficult to detect in traditional 
protein assay and staining methods. This technical complication can lead to 
contamination of bacterial outer membrane preparations with H.8 antigen (88).  
Gonococcal disease severity and symptoms differ based upon host gender. As 
published data are limited to male clinical trials and tissue culture models of 
infection, factors affecting colonization of women (uterine pH, hormonal cycles, 
vaginal secretions, normal flora, etc.) and their impact on infectious dose and 
subsequent disease sequelae, have not been fully explored. Specific physiological 
differences between genders have been shown to contribute to the complicated nature 
of gonococcal disease. For example, cervical epithelia in women express complement 
receptor type 3 (CR3) (89) and the female genital tract is a source of alternative 




neisserial outer membrane proteins porin and pilin have both been shown to bind CR3 
(92), and the lipid A portion of LOS likely serves as a site for C3b deposition on the 
bacterial cell surface (93). In addition, epithelial cells derived from vaginal, 
ectocervical and endocervical tissues have been shown to lack TLR4 and MD2, 
which are critical during host detection of LPS (94).  
Though some vaccine studies indicate the potential for the production of 
antibodies against gonococcal surface molecules, individuals who have had 
gonococcal infections can be re-infected by the very same strain (95-97). This occurs 
in spite of the fact that low gonococcal-specific antibody titers can sometimes be 
measured in previously infected individuals (98-100). This phenomenon indicates the 
lack of a protective memory response to gonococci (101).  
 Several aspects of host cell signaling in response to gonococcal contact have 
been examined. Gonococcal pili have been shown to bind CD46, inducing Ca2+ 
release from the intracellular stores of epithelial cells (102). Specific Opa proteins can 
bind HSPG and CEACAM (CD66) receptors, initiating internalization into epithelial 
cells. HSPG binding and uptake of gonococci has been shown to involve either 
phospholipase C and acid sphingomyeminase or the serum factors vitronectin or 
fibronectin (which can bind Opa50 and mediate bacterial internalization via integrin 
receptors and protein kinase C) (103-106). Gonococcal Opa binding of CEACAM 
receptors in phagocytes leads to activation of Src family kinases and downstream 
signaling through the stress response kinases: p21-activated protein kinase (PAK) and 
jun amino-terminal kinase (JNK) (107). Neisserial PorB has been shown to interfere 




cells (80, 108). Several signaling pathways activated by N. gonorrhoeae lead to 
activation of the transcription factors NF-κB (p50/p65 heterodimer) and activator 
protein 1 (AP-1) (35, 109, 110). Though TLR4/MD2 is important in recognition of 
neisserial LOS, activation of NF-κB during gonococcal challenge also occurs via 




Specific Aims and Approaches 
 
This study was designed to investigate modulation of the host immune 
response by N. gonorrhoeae. The central hypothesis for this work is that the outer 
membrane structures of N. gonorrhoeae, as well as the multiplicity of infection 
(MOI) can impact gonococcal interactions with human immune cells, contributing to 
different disease outcomes. Through the following dissertation I have explored the 
impact of gonococcal LOS, the H.8 antigen, and the initial bacterial dose during 
gonococcal challenge. 
In this study, I developed a monocyte/macrophage model and used it to 
analyze the initial host response to gonococcal infection. While neutrophil influx is 
certainly important in gonococcal disease, the initial elicitation of host immune 
response (including neutrophil influx) is the focus of this work. Gonococci are known 
to first colonize host urogenital epithelial cells (where they are likely to encounter 
resident macrophages and dendritic cells). However, they have also been shown to 
invade this tissue. As such, these bacteria must then come into greater contact with 
monocytes and other immune cells. Though in vitro epithelial cell models have been 
shown to produce low levels of cytokines after gonococcal challenge, this study asks 
whether the early interaction with monocytes/macrophages at or beyond the initial 
epithelial barrier may be a significant source of cytokines. I further hypothesize that 
production of proinflammatory cytokines and chemokines by these 
monocytes/macrophages could impact the host response. Gonococcal characteristics 




damage (e.g. TNFα) or the elicitation of neutrophils (i.e. IL-8) could dramatically 
affect disease presentation. 
In the following work I utilized several gonococcal LOS variants. Strain F62 
was originally isolated from the female urethra during uncomplicated gonococcal 
infection (114). F62 expresses the lacto-N-neotetraose LOS structure, which is 
associated with virulence (and is readily sialylated), and can also add a terminal N-
acetylgalactosamine to its LOS structure (61). A variant of F62, F62ΔlgtD, can only 
express the lacto-N-neotetraose LOS, with no phase variation. Strain F62ΔlgtA is 
another naturally occurring disease isolate, which expresses a truncated form of LOS 
that is associated with asymptomatic gonorrhea (61). A mutant strain of F62ΔlgtD 




• Previous work in our lab has demonstrated a role for the carbohydrate portion 
of the LOS molecule during invasion of epithelial cells (61). The role of LOS 
in cytokine production was analyzed by challenging monocytes with several 
isogenic variants that were genetically manipulated to express invariant 
structures with defined sugars. The effects of LOS sialylation on cytokine 






• Creation of an H.8- mutant in our laboratory (described in Chapter 2) allowed 
examination of the effects of this molecule on interactions with human 
monocytes. There exists little published work describing any role for H.8, 
though its conservation among neisserial pathogens implicates its importance 
during the disease process. The effect of H.8 on cytokine production as well 
as gonococcal interactions with macrophages was examined. 
 
Aim 3: 
• The last part of this study was designed to investigate the effects of bacterial 
dose upon the host response. In several studies, only a small percentage of 
gonococci have been shown to invade challenged epithelial cell monolayers 
(56, 93). It was therefore hypothesized that this small number of bacteria 
might elicit a different immune response than the high MOI challenges 






Materials and Methods: 
 
Bacterial strains and infection. Gonococcal strain F62 was obtained from Dr. P. 
Frederick Sparling (University of North Carolina, Chapel Hill, NC). F62ΔlgtD, a 
derivative of F62 that expresses a non-varying LOS, lacto-N-neotetraose, has been 
previously described (61). F62ΔlgtA, also a derivative of F62, expresses a fixed 
lactosyl LOS structure and has been previously described (61). Prior to each 
experimental challenge, gonococci were grown on GCK agar and piliated, Opa- 
organisms were selected. Bacteria were suspended in GCP broth supplemented with 
Kellogg's solution (115), the concentration of cells was determined 
spectrophotometrically and verified via viable plate count. Cells were killed by 
incubation for three hours with 2 mg/ml gentamicin sulfate. Bacteria were stored at 
4°C until challenge of human cells. Prior to bacterial challenge, gentamicin-killed 
bacteria were collected by centrifugation (12,000 rpm for 5 min.), resuspended in 
RPMI 1640 (Mediatech, Herndon, VA), and diluted as needed. Use of killed bacteria 
prevented growth and phase variation during the incubation period. For the 
preparation of bacterial lysates, live gonococci were diluted into PBS and sonicated. 
(Sonications were performed with a Branson Sonifier 250; 20 % duty cycle, output 
control = 4.) Sonication was carried out on ice, using twelve 15 second bursts, each 
followed by 30 seconds of cooling, for a total of 180 sec. Bacterial killing was 
confirmed by the absence of detectable bacteria on viable plate counts. For 




Ipswich, MA) or an Rc strain (E. coli Genetic Stock Center) as indicated. For 
experiments using LPS as a negative control, LPS was obtained from Sigma Chemical 
Co. (St. Louis, MO). Strain F62ΔlgtDH.8- was created as described in the results 
section of Chapter 2.  
 
LOS Extraction Procedure. Quick preparations of gonococcal LOS were prepared 
from plated bacterial cultures as described by Hitchcock and Brown (116). Cells were 
collected from plates using sterile swabs and resuspended in PBS to a Klett reading of 
100 (approximately 1x109 bacteria/ml). An aliquot of 1 ml was centrifuged at 10,000 
rpm and the pellet was re-suspended in 50 µl lysing solution [1M Tris-HCl (pH = 
6.8), 2% SDS, 4% 2-mercaptoethanol, 10% glycerol, bromophenol blue to 
saturation]. Proteinase K (10 µl of 1mg/ml stock) was added and the sample was 
incubated at 60°C for one hour. Samples were then diluted 1:25 in lysing solution. 
Prior to SDS-PAGE analysis, samples were boiled for 10 min and 5 µl was loaded 
onto the gel.  
 
H.8 purification and Western analysis. [This procedure was carried out by Dr. 
Daniel Stein.] Protein extracts from the parent and H.8- mutant were prepared by 
resuspending cells, isolated from an agar plate, in PBS to a Klett reading of 100. Cells 
were collected from a 1 ml aliquot of this preparation, resuspended in 50μl of lysing 
buffer, boiled for 10 minutes and a small aliquot analyzed on a 15%  SDS-PAGE gel 
(Usually 2.5 μl of sample was analyzed). (Gel was run at 100V until the dye front 




nylon membrane, and reactivity of the proteins determined by Western blotting using 
monoclonal antibody (mAb) 2-1-CA3, obtained from Dr. Sanjay Ram, to detect H.8. 
 
PCR.  [This procedure was carried out by Dr. Daniel Stein.] The gene encoding H.8 
was amplified from N. gonorrhoeae strain FA19 by PCR amplification using primers 
H8F (CCCGATCCTGCGGGATATAAACCCTGCCCTTTTGCCAATCC) and H8R 
(CCCGGATCCAAATCTTTGGCGCACTGGCGGACAAAGTCGGC) to amplify a 
3 kb fragment, with the H8 coding sequence located between bps 1623 and 1830. 
This PCR amplicon was digested with BamHI and cloned into the BamHI site of 
pUC19. After isolating an E. coli transformant containing the desired PCR amplicon, 
the resulting plasmid (puC19-H8) was used in a PCR reaction using primers H8IF 
(GGGCGTACGCATTTTCCGCTTGCAAAAAAGC) and H8IR 
(GGGCGTACGCTAAGCAGCGGCAAACAGGGA). This PCR amplification 
deleted 239 bp (almost all of the coding sequence for H.8) from pUC19-H8. This 
PCR amplicon was digested with BsiWI, self ligated, and introduced into E. coli. The 
resulting plasmid was named pUC19-H8Δ. A 2000 bp DNA sequence encoding the Ω 
interposon was amplified from pHP45 using primer OmegaABC, digested with BsrGI 
and inserted into the BsiWI site of pUC19-H8Δ. A spectinomycin resistant 
transformant of E. coli was isolated, and the plasmid was named pUC19-H8ΔSpec.  
N. gonorrhoeae strain F62(lgtDfixoff) was transformed with pUC19-H8ΔSpec, and 
spectinomycin resistant transformants were identified. DNA isolated from 
F62(lgtDfixoff)H8-spec7 and F62(lgtDfixoff) was used as a template for PCR, using 




fragment of 3000 bp, and yielded three fragments after digestion with HinCII (1595, 
1168 and 237 bp). 
 
Cell Lines.  THP-1 cells used were originally from the American Type Culture 
Collection (Manassas, VA) and were donated to our lab courtesy of Dr. David 
Mosser. Cells were grown in RPMI 1640 with 10% fetal bovine serum and 2 mM L-
glutamine, supplemented with 0.05 mM 2-mercaptoethanol. Fresh medium was added 
every 2-3 days or when cell concentrations exceeded 8x105 cells/ml. Prior to 
experimentation, cells were counted using a hemocytometer and plated at a 
concentration of 1x106 per ml. 
 
Isolation and culture of human monocytes/macrophages. Whole blood was drawn 
from healthy volunteers and peripheral blood mononuclear cells were prepared by 
density gradient centrifugation using Ficoll-Paque Plus. Briefly, blood was collected 
in heparinized tubes (BD Biosciences, San Jose, CA) and transferred to 50 ml conical 
tubes. The volume in each tube was brought to approximately 36 ml using warm PBS 
and cells were gently pipeted to ensure mixing. 14 ml of Ficoll-Paque Plus 
(Amersham Biosciences, Piscataway, NJ) was added beneath the blood suspension. 
(When necessary an untreated tube was used to collect blood for serum.) All blood 
tubes were centrifuged for 20 min at room temperature (RT), at 2500 rpm, and with 
the brake set to zero. This step was followed by transfer of the opaque layer 
(containing peripheral blood mononuclear cells) to a new 50 ml conical tube and 




tube. (Serum was heat inactivated for 25 min at 56°C prior to use in sample media.) 
Cells were centrifuged for 10 min at 4°C at 1500 rpm. The pellet was resuspended in 
a small volume of RPMI 1640, transferred to a 15 ml conical tube, and centrifuged 
for 10 minutes at 4°C, at 2500 rpm. Supernatants were aspirated and cells counted on 
a hemocytometer. Prior to bacterial challenges, cells were seeded at 1x106 cells/ml in 
tissue culture-treated plates in RPMI 1640 and incubated at 37°C, 5% CO2 with 
humidity. After 30 min, the cells were washed to remove the nonadherent population 
and RPMI 1640 (supplemented with 10% autologous heat-inactivated serum) was 
added preceding bacterial challenge. Differentiated macrophages were utilized in 
order to represent a resident macrophage phenotype, and provided a clear model for 
visualization of both NF-κB translocation and gonococcal orientation. For 
differentiation into macrophages, cells were seeded at approximately 5x105 cells/ml 
in untreated petri plates and maintained in RPMI 1640 supplemented with 20% heat-
inactivated fetal calf serum, 20 mM HEPES for seven days. On day seven, cells were 
washed and macrophages were removed from petri plates with Cell Stripper 
(Cellgro/Mediatech, Herndon, VA) and re-seeded onto glass coverslips for 
immunofluorescence staining and confocal microscopy.   
 
All studies employing human blood were approved by the University of Maryland’s 
Institutional Review Board (IRB #01321, “Immune Response to Gonococcal 





ELISA. Prior to bacterial challenge, primary human monocytes were isolated and 
seeded as described above. Following challenge with the appropriate dilution (100 μl) 
of gentamicin-killed gonococci, cells were incubated in RPMI 1640 supplemented 
with 10 % autologous human serum at 37°C 5 % CO2 with humidity for the time 
specified. Cell supernatants were collected and assayed for the presence of cytokines 
by sandwich ELISA. Upon collection of supernatants, a protease inhibitor cocktail 
was added and each sample was stored at -80°C until analysis. Antibody pairs and 
recombinant standards for human TNFα, IL-8, IL-10, and IL-12p40 were purchased 
from BD Pharmingen (San Diego, CA). (Any reference to IL-12 within this text 
refers specifically to IL-12 p40.) Antibody pairs, recombinant standards, and 
neutralizing antibody for human IL-1β were purchased from R&D Systems 
(Minneapolis, MN). ELISAs were carried out according to protocols provided by BD 
Pharmingen. Streptavidin alkaline phosphatase and p-nitrophenyl phosphate substrate 
were purchased from Southern Biotech (Birmingham, AL) and used according to the 
manufacturer’s specifications. Samples were read at 405 nm in 96-well, untreated, 
flat-bottom plates. In neutralizing experiments, 5 μg/ml TNFα neutralizing antibody 
was shown to completely bind all available TNFα in cell supernatants. Similarly, 2 
μg/ml IL-1β neutralizing antibody was shown to completely bind all available IL-1β 
in cell supernatants. 
 
Immunofluorescence staining and confocal microscopy. Human macrophages, 
differentiated from primary blood monocytes, were seeded overnight on sterile, acid-




translocation experiments: Macrophages were washed once in warm RPMI prior to 
the addition of 100 μl of the appropriate dilution of gentamicin-killed bacteria in 
RPMI and 300 μl RPMI supplemented with 10 % FCS. Cells were incubated at 37°C, 
5 % CO2 with humidity. At the specified time point, macrophages were washed once 
in warm PBS and fixed with cold methanol for 10 min. After incubation, 
macrophages were washed three times with PBS and blocked with PBS 5 % FCS for 
15 min at 37°C with humidity. A mouse monoclonal anti-NF-κB p65 (Santa Cruz 
Biotechnology, Santa Cruz, CA) was added to coverslips at a concentration of 1 
μg/ml in blocking buffer. Coverslips were incubated for 1 hr at RT with gentle 
agitation, washed twice in PBS and incubated with secondary antibody Alexa Fluor 
633 goat anti-mouse (Molecular Probes, Carlsbad, CA) in blocking buffer at 1 μg/ml, 
for 1 hr at RT with gentle agitation. Cells were washed twice in warm PBS and 
incubated with Alexa Fluor 546 phalloidin (1:50) for 30 min, washed once, and 
incubated with a 1:5000 dilution of SYTO 13 green fluorescent nucleic acid stain for 
20 min. Coverslips were washed three times in PBS prior to mounting and analysis. 
During analysis, fields were randomly chosen and at least 50 macrophages per sample 
were categorized as positive or negative for the presence of activated NF-κB p65 in 
the nucleus. For experiments using H.8- mutant gonococci: Macrophages were 
washed once in warm RPMI prior to the addition of 100 μl live bacteria (in RPMI 
1640) and 300 μl RPMI 1640 (supplemented with 10 % FCS) to give an MOI equal 
to 50. Cells were incubated at 37°C, 5 % CO2 with humidity for the indicated time. At 
the specified time point, media was aspirated and cells were fixed in cold methanol 




% FCS for 25 min at RT. Cells were stained with 0.008% Evans Blue (Sigma 
Aldrich, St. Louis, MO) for 30 min at RT, and incubated in a 1:5,000 dilution of 
SYTO 13 green fluorescent nucleic acid stain for 20 min at RT. Coverslips were 
washed four times with PBS prior to mounting.  
All coverslips were mounted using Gel/Mount anti-fading mounting medium 
(Biomeda, Foster City, CA). Samples were analyzed via laser-scanning confocal 
microscopy (LSM 510; Zeiss, Oberkochen, Germany). 
 
Activation/Inhibition of MAPK in monocytes treated with gonococci. Prior to 
infection, primary human monocytes were seeded overnight in 6-well tissue culture 
plates and incubated at 37oC, 5 % CO2. This overnight incubation was necessary in 
order to allow monocytes to return to expressing only basal levels of phosphorylated 
MAP kinases prior to detection by Western Blot. Post infection, the 6-well plates 
were placed on an ice bath and washed three times with ice-cold PBS. Lysates were 
collected by adding 100 μl of NP-40 lysis solution (1% NP40, 20 mM Tris-Cl, pH 
7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA, 10 μg/ml leupeptin and aprotinin 
protease inhibitors, 50 mM NaF, 1 mM sodium vanadate) to each well, scraping the 
cells from the plates, and pipetting the lysate into 1.5 ml microcentrifuge tubes. The 
lysates were placed on ice for 20-30 min and vortexed briefly every 7 min. All lysates 
were then centrifuged at 4oC for 30 min and the supernatants were transferred to a 
new 1.5 ml microcentrifuge tube and stored at -80oC. Protein concentration of the 




inhibited by pretreatment with PD98059, SB203580, or SP600125, 30 min prior to 
challenge with gonococci (Biosource, Camarillo, CA). 
 
SDS-PAGE and immunoblotting.  Lysates were prepared for SDS-PAGE by 
combining them with 2X loading buffer (50 % glycerol, 5 % SDS, 0.25 M Tris-Cl pH 
6.8, 0.04 % 2-mercaptoethanol, 25 μg/ml bromophenol blue) in a 1:1 ratio, boiling 
the samples for 5 min, and centrifuging them for 2 min at 12000 rpm. Equal volumes 
of each lysate were loaded into a gradient SDS-PAGE minigel and run at 0.01 
Amp/gel until the dye front just ran off the bottom of the gel (~ 110 min). Gels were 
equilibrated in 1X transfer buffer (25 mM Tris, 192 mM glycine, 15 % methanol, pH 
8.2) for 20 min while the PVDF transfer membranes (GE Osmonics, Trevose, PA) 
were prepared (10 sec in methanol, 5 min. in HPLC grade water, 15 min. in 1X 
transfer buffer). Proteins were transferred onto the PVDF membrane via wet, 
horizontal transfer at 100 V for 60 min at 4oC. The PVDF membranes were blocked 
overnight at RT in 1X PBS/0.05 % Tween 20%/ 1% fish skin gelatin (Sigma, St. 
Louis, MO). Membranes were washed twice in wash buffer (PBS/0.05 % Tween 20) 
and incubated in primary antibody solution (wash buffer, 1 % gelatin, 1:1000 rabbit 
anti-phospho p38 (Cell Signaling Technology, Beverly, MA), ERK, or JNK) for 90 
min at RT. After 5-15 min. washes in wash buffer, membranes were incubated in 
secondary antibody solution (1X PBS/0.5 % gelatin, 1:2000 goat anti-rabbit IgG-HRP 
conjugate) (Cell Signaling Technology, Beverly, MA) for 60 min. at RT followed by 
4, 15 min washes in wash buffer. Membranes were developed with luminal/peroxide 




autoradiography film (Marsh Bioproducts, Rochester, NY). To verify that equal 
amounts of lysate were loaded on the gel, the amount of β-actin in each lane was 
determined. The membrane was incubated in stripping buffer (62.5 mM Trizma base, 
2 % SDS, 100 mM 2-mercaptoethanol, pH 6.7) for 45 min at 50oC, washed 5 times 
with wash buffer and reprobed for actin protein following the same procedure as 
listed above with the following exceptions. The primary antibody was rabbit anti-β-
actin (Sigma, St. Louis, MO) at 1:2000 and the secondary antibody was goat anti-
rabbit (Sigma, St. Louis, MO) diluted 1:10000.  
 
Cytokine array. Primary human monocytes were isolated as described above and 
seeded into 24-well tissue culture plates at 1x106 cells/ml. The appropriate dilution 
(100 μl) of gentamicin-killed gonococci was added to each sample monolayer, and 
cells were incubated in RPMI 1640 supplemented with 10 % autologous human 
serum at 37°C, 5 % CO2 with humidity for 18 hrs. Supernatants from quadruplicate 
samples were pooled before addition to the array membrane. The RayBio Human 
Cytokine Array III was purchased from Raybiotech, Inc. (Norcross, GA) and used 
according to manufacturer’s instructions. Array membranes were analyzed using a 
Gel Doc camera and Quantity One software (Bio-Rad Laboratories, Inc., Hercules, 
CA). The volume array tool (for 96 wells) was used to specify area intensity for each 
spot within an image. A “background” volume was placed over the internal negative 
control for each array. The average intensity of pixels in this volume was calculated 
and subtracted from each pixel in all other volumes. This process resulted in 




the internal negative control). Positive controls from several exposures were 
compared and the means were found to be statistically similar (P > 0.05) using a 
paired, two-tailed, t test with a 95% confidence interval, thus allowing cross 
comparison of sample cytokine levels. Adjusted volumes (two for each cytokine) 






Chapter 1: The Effects of Lipooligosaccharide Structure on 
Human Monocytes 
Introduction 
     
The role of lipooligosaccharide (LOS) has been shown by many groups to be 
important in gonococcal disease pathogenesis (61, 117, 118). Harvey, et al. have 
demonstrated an important interaction between those gonococci expressing lacto-N-
neotetraose-terminal LOS and the asialoglycoprotein (ASGP) receptor of primary 
human urethral epithelial cells (119). Strains expressing lacto-N-neotetraose-terminal 
LOS were significantly more invasive than strains containing a deletion of the 
terminal Galβ1-4 and subsequent sugars (71). Song, et al. demonstrated that in the 
absence of Opa proteins, strains expressing specific LOSs (containing a terminal 
lacto-N-neotetraose) promoted increased gonococcal invasion of epithelial 
monolayers (61). In addition, gonococci predominantly expressing LOS with a 
specific carbohydrate structure have been associated with either symptomatology or a 
lack of symptoms in male clinical trials, further supporting the observation of 
pathogenic LOS phenotypes. Schneider, et al. demonstrated that after inoculating 
volunteers with low-molecular weight LOS variants, urethritis developed and 
primarily high molecular weight LOS (terminal lacto-N-neotetraose) was purified 
from the exudates (117). Thus, while the lipid A portion of the LOS molecule has 
historically been designated the immunogenic portion of the molecule, the 




Sialylation of LOS also impacts gonococcal interactions with host cells. 
Sialylated strains have been shown to be resistant to complement-mediated killing, to 
have a decreased ability to induce oxidative burst in neutrophils, and to possess a 
decreased ability to adhere to neutrophils in the absence of complement (62, 77). It 
has also been observed that the addition of CMP-NANA to gonococci (sialylation) 
reduces their ability to invade tissue culture epithelial cells (120). At present, further 
implications of LOS sialylation in the context of molecular mimicry remain unclear, 
though this process appears to be of significant biological importance. Since certain 
gonococcal LOS structures (potentially able to be sialylated) are associated with 
specific degrees of symptomatology, it is possible that LOS structure is integral in 
determining the severity of a gonococcal infection, and may serve to aid in evasion of 
the host immune system. 
 LPS is known to be highly immunostimulatory, and can elicit a variety of pro-
inflammatory cytokines and chemokines from host cells during infection. However, 
the immunostimulatory effects of gonococcal LOS during infection remain somewhat 
controversial. Several studies differ in their observations regarding the types and 
amounts of cytokines elicited. Some of these contradictions may stem from use of 
different bacterial strains, phase variation of LOS molecules in culture, and different 
cellular models of infection. In addition, the biological significance of LOS antigenic 
variation during infection has not been determined. In general, it is accepted that the 
tissue damage resulting from gonococcal infections can be attributed to the cytokine 
TNFα (12, 121). In addition, IL-8, IL-6, and IL-1β have been measured following 




occasionally naturally occurring infections in women have been monitored. 
Gonococcal cervicitis in female sex workers has been shown to cause increases in 
interleukin-4 (IL-4), IL-6, IL-10, and TNFα, as well as a decline in CD4+ T cell 
counts (123). Though IL-12 has not been detected in response to gonococcal 
challenge, this cytokine appears to be of significance during meningococcal 
infections (124). Cytokines such as TNF, IL-1β, IL-12, IL-10, MCP-1 (monocyte 
chemoattractant protein-1), IL-6, and RANTES (regulated upon activation, normal T-
cell expressed, and presumably secreted)  have also been measured during challenge 
with meningococcal LOS (124-127). 
Different LOS structures have been shown to correlate with disease 
symptomatology: F62 (lacto-N-neotetraose LOS) is associated with symptomatic 
gonococcal infection, while F62ΔlgtA (lactosyl LOS) is associated with 
asymptomatic gonococcal infection. In this study, I tested whether these naturally 
occurring LOS structures would differentially impact cytokine production by human 
monocytes. I hypothesized that compared with F62 and F62ΔlgtD (lacto-N-
neotetraose LOS) F62ΔlgtA (and its lactosyl LOS) would elicit lower levels of the 
cytokines associated with symptoms (such as TNFα). I further hypothesized that this 
strain might elicit greater production of IL-10, thereby suppressing pro-inflammatory 
responses. I investigated the ability of purified LOS and two distinct LOS variants to 
elicit cytokines, and also studied the effects of bacterial sialylation upon cytokine 
production. I chose to focus on measurement of the cytokines TNFα, IL-10, IL-12, 




regarding the overall disease model. During these studies both a human tissue culture 







Challenge of THP-1 cells with equivalent amounts of LOS/LPS from different 
variants results in similar production of TNFα and IL-12. In order to directly study 
the effects of LOS variation on human monocytic cytokine production, I challenged 
THP-1 cells with purified preparations of LOS. Using E. coli LPS as a positive 
control and unchallenged samples as a negative control, I was able to compare the 
LOS purified from wild type F62 with truncated LOS, purified from the F62ΔlgtA 
mutant. Analysis of cell supernatants by ELISA revealed no significant differences in 
the production of TNFα over a dose range, as seen in (Figure 4A). For subsequent 
experiments I chose to use 10 ng/ml LOS/LPS as an initial challenge dose, as it did 
not result in significant cell death, yet did result in measurable cytokine production. 
Measurement of IL-12 at two challenge doses similarly revealed no significant 
differences between F62 and the truncated mutant, as seen in (Figure 4B). 
Unchallenged samples did not result in measurable cytokine production. IL-10 
expression was also analyzed, but no values above the limit of detection by ELISA 
were obtained (data not shown). While it does appear that gonococcal LOS elicits 
significantly more TNFα from THP-1 cells than does E. coli LPS (Figure 4A), I 
attribute this to differences in the molar ratios of the two molecules, when used at the 











Figure 4: Production of TNFα and IL-12 by THP-1 cells challenged with 
purified LOS/LPS. 
 (A) Sample supernatants were collected 7 hrs after challenge of THP-1 cells 
(1x106/sample). These data are the result of two experiments, each performed in 
triplicate. Error bars indicate the standard deviation of the mean. (B) Sample 
supernatants were collected 16 hrs after challenge of THP-1 cells 1x106/sample. 
These data represent one experiment, performed in triplicate. Error bars indicate the 







Challenge with distinct gonococcal LOS variants elicits similar levels of TNFα and 
IL-12. I hypothesized that the LOS on whole bacteria may be presented differently to 
monocytes than purified LOS. In order to test this, I challenged THP-1 cells with two 
variants of live gonococci. IL-12 was measured at 18 hours after challenge with a 
range of bacterial doses and levels were shown to be equal between variants (Figure 
5). Similarly, no difference in TNFα was observed between challenge phenotypes. 
Challenge with whole-cell bacteria however, did result in greater production of TNFα 
when compared with the molar equivalent challenge dose of LOS (Figure 6). The 
same trend was evident for IL-12 (data not shown). (Molar equivalencies were 
previously determined by Dr. Daniel Stein: purified LOS preparations were weighed, 
and dilutions of these samples along with dilutions of LOS from whole cell 
preparations, were analyzed via SDS-PAGE.) Since this observation was likely to 
have resulted from growth of the bacteria in vitro, I eliminated this variable by using 
gentamicin sulfate to kill the gonococci prior to challenge. Gentamicin is an 
aminoglycoside antibiotic and binds directly to ribosomal RNA, thereby inhibiting 
protein synthesis (128). Use of this antibiotic does not cause lysis of the bacteria. 
Upon staining and visualization of killed bacteria, the cells appeared as normal 
diplococci (data not shown). As shown in Figure 7, killed gonococci elicited less IL-
12 than live gonococci and no differences were observed between LOS variants. To 
avoid the complication of in vitro gonococcal growth as well as phase variation, 









Figure 5: Production of IL-12 by THP-1 cells challenged with live gonococcal 
variants over a dose range. 
Various doses of live gonococci were added toTHP-1 cells (1x106/sample). At 18 
hours post infection, supernatants were collected and analyzed by ELISA. Data 
shown are from one experiment, performed in triplicate. Error bars indicate the 













Figure 6: Comparison of TNFα production upon challenge with live gonococci 
vs. challenge with purified LOS. 
THP-1 cells (1x106/sample) were challenged with either 1x105 live gonococci or a 
molar equivalent amount of LOS/LPS (10 ng/sample). At three hours post challenge, 
sample supernatants were analyzed for TNFα by ELISA. These data represent two 
experiments, each performed in triplicate. Error bars indicate the standard deviation. 


















Figure 7: Production of IL-12 upon challenge with live vs. gentamicin-killed 
gonococci. 
THP-1 cells (1x106/sample) were challenged with either 1x105 live or gentamicin-
killed gonococci. At 18 hrs post challenge, IL-12 was measured by ELISA. These 


















Challenge of primary human monocytes with two LOS variants reveals similar 
elicitation of TNFα, IL-10, IL-12, and IL-8. In order to examine the effects of LOS 
variation in a primary cell model, we utilized monocytes derived from human whole 
blood. These primary cells were challenged with two variants of gentamicin-killed 
gonococci, F62ΔlgtA (as described above) and F62ΔlgtD which expresses a fixed 
terminal lacto-N-neotetraose structure (61). F62ΔlgtD was used in order to ensure that 
no variation of LOS was occurring. After incubation, sample supernatants were tested 
for the presence of TNFα, IL-10, IL-12, and IL-8. Over the dose range tested, no 
differences in cytokine production were observed when comparing the two variants 
(Figure 8). However, these data demonstrate that gonococci can elicit all four of these 
cytokines from human monocytes. In addition, a large amount of the chemokine IL-8 
was elicited by gonococci, implying a significant role for this chemokine during 





Figure 8: Production of TNFα, IL-10, IL-12, and IL-8 upon challenge of primary 
human monocytes. 
Monocytes were isolated from human whole blood and cells (1x106/sample) were 
challenged with varying doses of gentamicin-killed gonococci. Sample supernatants 
were collected at 18 hrs post challenge and cytokines were analyzed by ELISA. Clear 
bars indicate challenge with F62ΔlgtD and shaded bars indicate challenge with 
F62ΔlgtA Challenge with media alone resulted in no measurable TNFα or IL-10 and 
less than 100 pg/ml IL-12; Approximately 1 ng/ml IL-8 was measurable from 
negative controls, with a standard error of 0.8 ng/ml. (A) TNFα (B) IL-10 (C) IL-8 
(D) IL-12 These data represent three experiments, each performed in triplicate.  Error 
































Sialylation of gonococcal LOS does not alter production of TNFα or IL-12. Since 
sialylation of gonococcal LOS is likely to play a role in natural infection, I 
determined its effects on monocytic cytokine production. After growing gonococci in 
the presence of CMP-NANA, the bacterial LOS was extracted and analyzed via 
polyacrylamide gel electrophoresis. This process confirmed the efficacy of the 
sialylation procedure. Figure 9A shows a low molecular weight band for F62ΔlgtA 
(representing the lactosyl LOS), two bands for wild type F62 (one representing the 
terminal lacto-N-neotetraose, and one representing an increase in molecular weight as 
lgtD phase varies to add a terminal N-acetylgalactosamine). Sialylation of F62, 
represented by the center band, shows a shift in molecular weight of the lower band 
as sialic acid is added to the terminal sugar. Figure 9B shows wild type F62 and the 
F62ΔlgtD gonococcal variant expressing only the fixed lacto-N-neotetraose LOS 
structure, and sialylated F62ΔlgtD (a shift in molecular weight shows addition of the 
terminal sialic acid). Figure 9C shows the result of two challenge experiments 
utilizing the sialylated gonococci. There was no significant difference observed in 
either IL-12 or TNFα production as a result of challenge with sialylated bacteria. 
Therefore sialylation of gonococcal LOS does not appear to play a role in altering 
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Figure 9: Production of TNFα and IL-12 upon challenge with gonococci 
expressing sialylated LOS.  
Bacterial LOS was analyzed via polyacrylamide gel electrophoresis. (A) LOS 
samples shown (from left): F62ΔlgtA, F62 grown in the presence of CMP-NANA 
(sialylated), and wild type F62. (B) LOS samples shown (from left): wild type F62, 
F62ΔlgtD, and F62ΔlgtD grown in the presence of CMP-NANA (sialylated). (C) 
THP-1 cells (1x106/sample) were challenged with sialylated and unsialylated N. 
gonorrhoeae. Cytokine production in sample supernatants was measured by ELISA. 
Left panel: IL-12 levels after an 18 hour challenge of THP-1 cells (1x106/sample) 
with 1x102 live N. gonorrhoeae. Right panel: TNFα levels after 7 hour challenge of 
THP-1 cells (1x106/ml) with 1x108 gentamicin-killed gonococci. (S) represents 
sialylated samples (grown in the presence of CMP-NANA). Challenge with media 




Gonococcal sialylation elicits production of MCP-2. In order to further study whether 
sialylation of gonococcal LOS alters monocytic cytokine production, I utilized a 
cytokine array. This assay allowed simultaneous measurement of 42 different 
cytokines in samples. Challenge with gonococci resulted in upregulation of several 
cytokines including: GRO (growth regulated oncogene), IL-1β, IL-6, IL-10, GM-CSF 
(granulocyte-macrophage colony stimulating factor), TNFα, MDC (macrophage-
derived chemoattractant), and RANTES when compared to samples challenged with 
media alone. Several cytokines [IL-8, MCP-1, and PDGF-B (platelet-derived growth 
factor-B)] were also measurable in unchallenged samples. There is a slight disconnect 
between cytokines measured in this assay compared with those measured previously 
by ELISA. No IL-12 was measurable during the array experiment and I attribute this 
to the different antibody pairs used in printing the array. In addition, IL-8 did not 
appear to be significantly upregulated between unchallenged and challenged samples 
since the spots were saturated on both arrays chosen for analysis. Even upon 
examination of a one second exposure, values for the IL-8 spots far exceeded positive 
control values. In addition, positive control values from these early exposures did not 
fall in the linear range, and therefore these arrays could not be included in the 
statistical analysis (data not shown). However, previous analysis by ELISA allowed 
me to quantify the IL-8 produced during challenge.  
Interestingly, challenge with sialylated gonococci caused production of MCP-
2 (monocyte chemoattractant protein-2) in comparison with unsialylated gonococci 
(Figure 10). MCP-2 was not detected in unchallenged samples or those challenged 







    
 





Figure 10:  Comparison of MCP-2 production upon challenge with either 
F62ΔlgtD or sialylated F62ΔlgtD. 
Primary human monocytes (1x106/ml) were challenged with gentamicin-killed 
gonococci (1x107) for 18 hours prior to analysis of sample supernatants using a 
protein array to detect the presence of cytokines. Densitometric analysis was carried 
out using a Gel Doc 2000 camera and Quantity One Software (BioRad Laboratories, 
Inc.). Analysis of internal positive controls (+) among array exposures using a paired, 
two-tailed, t test with a 95% confidence interval indicated that the means were 
statistically similar (P > 0.05), allowing cross comparison of sample cytokine levels. 
(A) Whole array for each sample: (-) negative control, F62ΔlgtD , and F62ΔlgtD (S) 
Dashed boxes indicate the location of MCP-2 antibodies spotted on the array 
membrane. (B) Internal positive controls compared with MCP-2. Data shown are 






are necessary in order to quantitate the observed differences in MCP-2 production. A 
variety of immune cells are targets for this chemokine and chemotactic responses 
have been shown to differ depending upon the concentration of MCP-2 in vivo. 
Quantitation of MCP-2 regarding these gonococcal challenge experiments would 










Gonococcal LOS is an important surface molecule in disease. In this study, I 
measured the production of a variety of cytokines from monocytes during gonococcal 
challenge. The data demonstrate that alterations in the carbohydrate moiety of LOS 
do not impact the production of most cytokines by human monocytes. However, 
whole-cell bacterial challenge was more stimulatory than challenge with purified 
LOS, implying an important role for other surface structures with regard to cytokine 
elicitation. Interestingly, sialylation of LOS resulted in elicitation of the chemokine 
MCP-2 from challenged cells. As the LOS structure associated with symptomatic 
infection (lacto-N-neotetraose) is readily sialylated in vivo, differential elicitation of 
cytokines due to sialylation could significantly impact disease progression by 
increasing the response of specific immune cell types. 
Though several groups have measured cytokine production during in vitro 
challenge with N. gonorrhoeae, controversy exists with regard to which cytokines are 
produced and in what quantities. In this study, I observed production of TNFα, IL-12, 
IL-10, and IL-8 by monocytes in response to whole-cell gonococcal challenge as well 
as in response to challenge with purified LOS. However, whole cell gonococci 
elicited a much greater response than purified LOS/LPS. Since these experiments 
were performed, this observation has been confirmed by several groups studying N. 
meningitidis. It has been demonstrated that N. meningitidis deficient in detectable 
LOS (LpxA-) causes substantial cytokine production from human peripheral blood 




meningococci have been shown to be more potent inducers of several cytokines than 
equal amounts of purified LPS (130). In contrast, Unkmeir, et al. reported that 
challenge of dendritic cells with an N. meningitidis strain lacking LOS resulted in 
almost undetectable levels of TNFα, IL-6, and IL-8 (132). However, this difference 
may be related to the use of dendritic cells as a model. These data, along with my 
observations, indicate that a substantial portion of the cytokines elicited from 
gonococcal interactions with monocytes, result from non-LPS components.  
During these experiments I observed no difference in the elicitation of TNFα, 
IL-10, IL-12, or IL-8 between gonococcal LOS variants. Based on these observations, 
I believe that while the carbohydrate portion of the LOS molecule is important for 
pathogenesis of the organism, it does not play a significant role in determining host 
cytokine profile during gonococcal encounters with monocytes. Similar conclusions 
have been reached by other groups since these experiments were performed. 
Pridmore, et al. challenged THP-1 cells with purified LOS (200 ng) from different 
neisserial strains and measured TNFα production and signaling through TLR4/MD2 
(113). Some variability was observed, although this did not correspond with 
oligosaccharide structure of the strains. Braun, et al. demonstrated that N. 
meningitidis variants expressing LOS immunotypes isolated from diseased patients 
induced significantly higher levels of TNFα and IL-6 when compared with 
immunotypes primarily associated with carriers of the bacteria (133). However, the 
immunotypes that differed in their ability to induce cytokine production each 
expressed identical oligosaccharide moieties. Interestingly, disruption of the lpxLII 




molecule, resulting in mutants with a reduced ability to induce TNFα, IL-1β, IL-6, 
and IL-8 from a human macrophage model (134). 
Taken together, these data imply that differences in the immunostimulatory 
potential of gonococcal LOS variants during interactions with human monocytes 
originate from alterations in the lipid A structure. This hypothesis is supported by the 
fact that acylation patterns of the lipid A portion of meningococcal LOS have been 
demonstrated to be important in determining levels of TNFα elicited from a human 
macrophage cell line (135).  
It has been previously shown that when dendritic cells are challenged with N. 
meningitidis, optimal production of TNFα and Il-12 only occurs upon internalization 
of the bacteria (124). In addition, this internalization appeared to be dependent on 
expression of LOS, as an LOS-deficient mutant was internalized poorly compared to 
wild type bacteria (124). In future studies, it would be interesting to study the effects 
of gonococcal oligosaccharide alterations during interactions with other cellular 
models, such as dendritic cells. In addition, measurement of internalization, as well as 
cytokine production during challenge of human macrophages with gonococcal lipid A 
mutants, may provide significant insight into gonococcal pathogenesis.  
Data collected from these experiments allowed a broad look at the cytokine 
profile of monocytes after gonococcal challenge. A variety of cytokines and 
chemokines were measurable during infection including: GRO, IL-1β, IL-6, IL-10, 
IL-12, GM-CSF, TNFα, MDC, and IL-8. The cytokine profile I observed differed 
slightly from that observed by Makepeace, et al., who utilized a differentiated human 




several cytokines (including TNFα, IL-6, MIP-1α, and RANTES) was measured, no 
secretion of IL-1β, ENA-78, GM-CSF, IL-10, or IL-12 was reported. Since I was able 
to measure IL-1β, GM-CSF, IL-10 and IL-12 during challenge, it is possible that use 
of differentiated cells, a different gonococcal strain (P9), and a higher infectious dose 
(MOI = 400) by this group explains these differences with regard to my own 
observations. Further analysis of the roles of the cytokines and chemokines measured 
in this study could significantly contribute to our understanding of gonococcal 
disease.  
Sialylation of gonococcal LOS has been previously shown to convert serum 
sensitive strains to a serum resistant phenotype (137-139). However, sialylation has 
also been shown to play a role in other aspects of gonococcal pathogenesis including 
interactions with antibodies and phagocytes [for review see (62, 73, 140)]. In these 
studies, sialylation of gonococcal LOS prior to challenge of THP-1 cells resulted in 
similar production of TNFα or IL-12. These experiments were followed by use of an 
array to examine cytokine production from challenged primary monocytes. This work 
demonstrated that sialylated gonococcal challenge samples exhibited upregulation of 
MCP-2 (in comparison to unchallenged samples and those challenged with 
unsialylated bacteria). MCP-2 is a low molecular weight monocyte chemotactic 
cytokine which is closely related to MCP-1 and MCP-3 (129). Target cells for MCP 
include monocytes, T lymphocytes, natural killer cells, eosinophils, and basophils, 
though monocytes are the most sensitive. The concentration of MCP-2 present in 
vitro has been shown to differentially activate specific target cell populations (129). 




infection. A human mononuclear cell model was utilized, though gonococci were not 
sialylated prior to challenge (141). As LOS molecules associated with symptomatic 
infection and increased invasiveness are readily sialylated in vivo, production of 
MCP-2 during infection may substantially increase the response of a specific cellular 
population during gonococcal infection. Future determination as to the quantities of 
MCP-2 produced during monocyte interactions with sialylated gonococci may 
provide insight into the pathogenesis of these more virulent strains. In addition, 
further analysis of the mechanism by which sialylated LOS causes production of 
MCP-2 may significantly add to our knowledge of the pathogenesis of N. 
gonorrhoeae. In summary, though alterations in the carbohydrate portion of LOS do 
not appear to effect cytokine production by human monocytes, sialylation of LOS 























Figure 11: Schematic diagram summarizing the observed interactions of human 
monocytes with gonococci expressing various LOS structures. 
Gonococci expressing the lactosyl LOS and the lacto-N-neotetraose LOS were 
observed to cause production of the same cytokines by human monocytes. Upon 
sialylation of gonococci expressing lacto-N-neotetraose LOS, an increase in 





























 N. gonorrhoeae expresses many surface molecules that undergo significant 
antigenic variation. However, the H.8 antigen (or Lip lipoprotein) is a surface-
expressed lipoprotein that is conserved among Neisserial pathogens (84, 85) 
Immunogold-labeling of this antigen has demonstrated its relative abundance and 
uniform distribution on the bacterial cell surface (84). The H.8 antigen is named for a 
monoclonal antibody that recognizes an epitope common to N. gonorrhoeae and N. 
meningitidis, but not to most commensal Neisseria species (83). Not only is this 
lipoprotein abundantly expressed on the gonococcal cell surface, but it has also been 
found in membrane blebs (84, 142).  
 Though the cell membranes of Gram negative bacteria contain many different 
lipoproteins, few of these have been characterized biochemically. Most bacterial 
lipoproteins appear to be triacylated at the amino terminus, while the lipoproteins 
found on mycoplasmas are diacylated and have a free amino group (111). Lipid 
modification of the neisserial H.8 antigen has not been completely elucidated, 
however analysis by Fisette, et al. suggests that its lipid component can be composed 
of C16 fatty acid and a shorter C8-C10 lipid (111). The H.8 antigen has been difficult to 
characterize due to several unusual properties. It does not stain with Coomassie blue 




aberrantly in two-demensional gels (84). The purified protein component of Lip has 
been demonstrated to be rich in glutamate, alanine and proline, and lacks aromatic 
amino acids and methionine (143). The amino-terminus of Lip is a cysteine residue. 
Analysis of this protein from strain FA1090 reveals that it is 71 amino acids in length 
and is composed of a number of pentameric repeats (AAEAP). Perfect five-residue 
periodicity is maintained throughout (143). The H.8 lipoprotein shows some 
similarity to other microbial proteins with repetitive motifs such as the Streptococcal 
M protein and Lpp of E. coli. While these lipoproteins serve structural roles in the 
outer membrane, the Streptococcal M protein has also been shown to have an 
antiphagocytic function (143).  
The role of H.8 in gonococcal pathogenesis is unclear. Several aspects of the 
host response to this molecule have been previously investigated. H.8-specific 
antibodies were measured in serum from patients with disseminated gonococcal and 
meningococcal infections (95). In addition, alterations in the molecular weight of H.8 
have been shown to correspond with alterations in gonococcal serum sensitivity (84). 
Purified preparations of H.8 have been shown to elicit cytokine production from 
epithelial cells, and promote NF-κB activation (111).  
The gonococcus is constantly altering many of its surface structures. 
However, since N. gonorrhoeae does not elicit a dramatic antibody response in 
infected hosts and re-infection with the same strain is common, the host response to 
H.8 does not appear to impede colonization/ disease progression. Therefore, it is 
unusual that the H.8 antigen is conserved among the pathogens and that it is 




In this study, I investigated the role of the H.8 antigen in the elicitation of pro-
inflammatory cytokines from monocytes and in the cell-cell interactions between 






Construction of an H.8 negative strain. [The following section (including Figure 12) 
incorporates experiments performed by Dr. Daniel Stein.] The gene encoding H.8 was 
PCR-amplified from N. gonorrhoeae strain FA19. After isolating an E. coli 
transformant containing the desired PCR amplicon, the resulting plasmid (pUC19-
H8) was used in a PCR reaction. This PCR amplification deleted 239 bp (almost all of 
the coding sequence for H.8) from pUC19-H8. This PCR amplicon was digested with 
BsiWI, self ligated, and introduced into E. coli. The resulting plasmid was named 
pUC19-H8Δ. After successful insertion of a spectinomycin resistance-encoding gene 
(from the Ω interposon) into this plasmid, a spectinomycin resistant transformant of 
E. coli was isolated (pUC19-H8ΔSpec). After transformation of N. gonorrhoeae 
strain F62(lgtDfixoff) (with pUC19-H8ΔSpec), one transformant (F62(lgtDfixoff)H8-
spec7) was chosen for further analysis. The correct insertion of the Ω interposon 
encoding sequence and deletion of the H.8 encoding sequence in F62(lgtDfixoff)H8-
spec7 was verified by PCR analysis. DNA isolated from F62(lgtDfixoff)H8-spec7 
and F62(lgtDfixoff) was used as a template for PCR and the amplicon generated from 
F62(lgtDfixoff) generated a fragment of 3000 bp, and yielded three fragments after 
digestion with HinCII (1595, 1168 and 237 bp). Since the Ω-interposon encoding 
sequence correctly inserted into the chromosome of F62(lgtDfixoff)H8-spec7, a 4824 
bp fragment was successfully amplified, and yielded three fragments after digestion 
with HinCII (3419, 1168 and 237 bp). The data presented in Figure 12A indicate that 




interposon correctly replaced the H.8 coding sequence. Protein extracts from the 
parent and H8- mutants were isolated and reactivity of the proteins was determined by 
Western blotting, using mAb 2-1-CA3, obtained from Dr. Sanjay Ram (Boston 
University), to detect H.8 (Figure 12B).  
 
H.8 does not affect human monocytic cytokine production. The impact of the H.8 
antigen during the initial stages of gonococcal disease is unknown. Since I have 
hypothesized that gonococcal interactions with monocytes may be an important step 
in determining disease progression, I chose to analyze the effect of H.8 on the 
production of several cytokines by these cells. Initially, THP-1 cells were challenged 
with either the parent strain (F62ΔlgtD) or the H.8- mutant (F62ΔlgtDH8-). 
Gentamicin-killing of bacteria prior to the challenge ensured that no phase variation 
or bacterial growth would occur during the 18 hr incubation. Sample supernatants 
were analyzed for the presence of TNFα and IL-12 (Figure 13). No differences in the 
levels of these cytokines were observed. After noting the apparent importance of IL-8 
production during gonococcal challenges of primary human monocytes (see Ch.1, 
Figure 8), I chose to use this same model in order to study potential H.8-dependent 
differences in IL-8 production. However, I observed no effect upon the production of 
IL-8 due to challenge with the H.8- mutant in comparison with the parent strain 
(Figure 14). In order to more broadly analyze the cytokine production of primary 
human monocytes in response to our H.8- mutant, I utilized a cytokine array. Through 




Figure 12: Constuction of an H.8- strain. 
 (A) Data indicate the replacement of the sequence for H.8 with the Ω interposon. The 
lanes represent: 1) λ DNA digested with HinCII, 2 ) amplicon generated from 
F62(lgtDfixoff) and 3) its digestion with HinCII (1595, 1168 and 237 bp), 4) Ω-
interposon insertion and 5) its digestion with (HinCII, 3419, 1168 and 237 bp). (B) 
SDS-PAGE and Western blot analysis of H.8 expressed by N. gonorrhoeae strain 
F62ΔlgtDH.8- and its derivative. Lanes 1 and 2 represent SDS-PAGE analysis: 1) 
parent strain and 2) F62ΔlgtDH.8-. Lanes 3 and 4 represent Western analysis using an 































Figure 13: Challenge of THP-1 cells with an H.8- mutant.  
Parent strain (+) F62ΔlgtD (clear bars), and its corresponding H.8- mutant (shaded 
bars) were gentamicin-killed and added to THP-1 (106 per sample) at an MOI of 10. 
After an18 hr incubation, sample supernatants were analyzed by ELISA for the 
presence of TNFα (A) and IL-12 (B). Data shown are from one experiment 
performed in triplicate and are representative of two independent experiments. Error 








Figure 14: Challenge of primary human monocytes with H.8- gonococci.  
Monocytes (106 per sample) were challenged for 18 hrs with either gentamicin-killed 
(+) F62ΔlgtD (clear bars) or the H.8- mutant (shaded bars). Sample supernatants were 
analyzed by ELISA for the presence of IL-8. Data shown are from one experiment, 
performed in triplicate, and are representative of two independent experiments. (-) 
indicates monocyte samples challenged with media alone. Error bars indicate the 






different cytokines. As mentioned in Chapter 1, when comparing samples challenged 
with gonococci to those challenged with media alone I observed upregulation of 
several cytokines including: GRO, IL-1β, IL-6, IL-10, GM-CSF, TNFα, MDC, and 
RANTES. Some cytokines including IL-8, MCP-1 and PDGF-B were also 
measurable in unchallenged samples. When comparing between samples challenged 
with F62ΔlgtD and the H.8- mutant I observed a difference between GM-CSF, TNFα, 
and RANTES (Figure 15). The level of RANTES was measured to be slightly higher 
in the H.8- samples, while GM-CSF and TNFα were measured to be lower in H.8- 
samples. However, none of these cytokines was determined to be significantly 
different between samples (2-fold change or greater). Therefore, I can conclude that 
production of most proinflammatory cytokines is not impacted by the H.8 antigen. As 
previously observed using this assay (Chapter 1), the level of IL-8 between 
challenged and unchallenged samples was not measured to be significantly different. I 
have however, previously shown a significant difference in production of this 
cytokine by ELISA (Figure 14). Since the cytokine array only allows determination 
of qualitative differences, it may be that the fold change between samples was not 
great enough to be reflected in my analysis. For example, the difference in IL-10 
between challenged and unchallenged samples appeared, by array analysis, to be 
great. However quantitation by ELISA demonstrates very low levels of IL-10 present 
in samples. Therefore, intensity measured during array analysis does not reflect actual 








Figure 15: Comparison of cytokine levels from challenge with either F62ΔlgtD or 
the H.8- mutant. 
Primary human monocytes (1x106/sample) were challenged with gentamicin-killed 
gonococci for 18 hours prior to analysis of sample supernatants using a cytokine 
array. Densitometric analysis was carried out using a Gel Doc 2000 camera and 
Quantity One Software (BioRad Laboratories, Inc.). Analysis of internal positive 
controls (+) among array exposures using a paired, two-tailed, t test with a 95% 
confidence interval indicated that the means were statistically similar (P > 0.05), 
allowing cross comparison of sample cytokine levels. Shown are internal positive 
controls and three cytokines measured to be slightly different between challenge 






H.8 alters bacterial distribution during cell-cell contact. In order to examine the 
physical interactions between H.8- gonococci and human cells, I utilized a human 
monocyte-derived macrophage model. Use of these cells allowed clear visualization 
of cellular structures and relative orientation of the bacteria. Live bacteria (F62ΔlgtD 
and F62ΔlgtD H.8-) were diluted and added to macrophage monolayers at an MOI of 
50. Cells were incubated at 37°C for 120 min. before fixation in methanol. 
Macrophages were stained and analyzed by confocal microscopy. During analysis, 
macrophages were examined and classified into two categories: those interacting with 
a large number of bacteria (>100 group) and those interacting with very few bacteria 
(<20 group). Initially, I compared the parent strain with the H.8- mutant and 
determined that approximately 70% of macrophages were interacting with large 
groups of bacteria and approximately 20% were interacting with only a few bacteria 
(Figure 16A). [A very small number of macrophages (<1%) did not appear to be 
interacting with any bacteria. These cells were not included in my analysis.] In the 
case of macrophages interacting with large numbers of bacteria, the bacterial cells 
appeared to be either evenly distributed or were arranged in distinct aggregates. 
Figure 16B shows several representative images of macrophages classified as 
interacting with “distributed” bacteria or “bacterial aggregates.” I observed a striking 
difference in bacterial orientation in samples challenged with the H.8- mutant. 
Examination of at least 60 macrophages per sample revealed that approximately 65% 
of these macrophages (in the >100 group) were in contact with large bacterial 
aggregates, compared with approximately 15% of those challenged with the parent 




Figure 16: Bacterial cell distribution upon challenge of human macrophages.  
Live bacteria were added to macrophages (MOI = 50) as described in the methods, 
and incubated for 120 min. Cells were fixed with methanol and coverslips were 
stained with SYTO 13 green fluorescent nucleic acid stain (green) and Evan’s Blue 
(red) prior to analysis by confocal microscopy. Macrophages were categorized after 
blind image capture of randomly selected fields. (A) Percentage of macrophages 
classified as interacting with more than 100 or less than 20 bacteria. (n > 60 for each 
sample.) Data represent the average of two independent experiments and error bars 
indicate the standard deviation of the mean. Clear bars indicate challenge with 
F62ΔlgtD and shaded bars indicate challenge with the H.8- strain. (B) Confocal 
images which represent the categories used to classify bacterial orientation in the 
>100 group. (C) Percent of macrophages interacting with evenly distributed bacteria 
vs. bacterial cell aggregates in the >100 group. (n > 60 macrophages categorized in 
each sample.) Data represent the average of two independent experiments and error 

















Bacterial cell orientation is not altered prior to contact with macrophages. After 
observing the increased aggregation of H.8- mutants, I hypothesized that since H.8 has 
an overall negative charge, this observation may be due to the altered surface charges 
of the H.8- mutants. As a result, the mutant gonococci would be more likely to 
aggregate in general, independent of contact with macrophages. In order to test this 
hypothesis, I challenged human macrophage monolayers over a time course. Samples 
were incubated at 37°C for 5, 30, 60, and 120 min post challenge, prior to fixation 
with methanol. Samples were then stained and analyzed via confocal microscopy. 
Figure 17 shows two representative images for each time point, with the exception of 
5 min. In the 5 min samples, no bacteria were visible. I attribute this observation to 
the fact that the minimum time for bacterial attachment in this system must be greater 
than 5 min. Therefore, most of the bacteria were likely removed upon aspiration of 
the samples, and during post-fixation washing. At the 30, 60, and 120 min time 
points, H.8- gonococci can be seen arranged as diplococci when they are not 
interacting with macrophages. However, the majority of those bacteria in direct 
contact with macrophages were observed to form aggregates or microcolonies. In 
comparison, the parent strain appeared to be taken up by the macrophages over time, 
and few large aggregates were observed. These data indicate a possible role for the 
H.8 antigen during recognition and phagocytosis by immune cells.  
In order to further study the distribution of the H.8- mutants in contact with 
human macrophages, I examined the three-dimensional arrangement of the bacteria. 
Cross-sectional images of a cell interacting with a large number of evenly distributed 







Figure 17: Bacterial cell distribution over time. 
Live bacteria were added to macrophages (MOI = 50) and incubated over a time 
course. Cells were fixed with methanol and coverslips were stained with SYTO 13 
green fluorescent nucleic acid stain (green)and Evan’s Blue (red) prior to analysis by 
confocal microscopy. One representative image per time point is shown for both 





throughout the macrophage, and many appear to be localized within vacuoles. In 
contrast, several macrophages interacting with large bacterial aggregates 
(F62ΔlgtDH.8-) are shown in Figure 18B. These data indicate that the H.8- gonococci 
are not readily taken up by macrophages in comparison with wild type bacteria. This 
implies that the H.8 antigen may be recognized by macrophages, serving as an 









Figure 18: Cross-sectional analysis of challenged macrophages. 
Live bacteria were added to macrophages (MOI = 50) and incubated for 120 min. 
Cells were fixed with methanol. Cells were stained with SYTO 13 green fluorescent 
nucleic acid stain (green) and Evan’s Blue (red) prior to analysis by confocal 
microscopy. Images from 1 to 8 show cross-sections from the surface of the cells (1) 







 The function of the neisserial H.8 antigen remains undefined, though its role 
in disease is likely to be significant. The structural properties of this molecule have 
been studied, but few groups have performed experiments to characterize its impact 
upon the human immune system. Only one other group has created a gonococcal 
mutant lacking H.8, however no studies regarding interactions of this mutant with 
host cells have been reported (87). Generation of an H.8- strain in our laboratory 
allowed direct comparison of the effects of this antigen on gonococcal interactions 
with human monocytes and macrophages. Though I observed no significant role for 
H.8 in cytokine elicitation, this molecule appears important during recognition by 
host macrophages (Figure 19).  
Initially, I measured the elicitation of the cytokines TNFα, IL-12, IL-10, and 
IL-8 from monocytes challenged with both wild type N. gonorrhoeae and H.8- 
mutants. I observed no differences in the production of these cytokines when using 
either a human monocytic cell line or human primary monocytes. After more broadly 
analyzing this response using a cytokine array, RANTES was measured to be slightly 
higher in the H.8- samples, while GM-CSF and TNFα were measured to be lower in 
H.8- samples. However, these differences were not determined to be significant. 
Therefore, I concluded that the H.8 antigen does not appear to impact the elicitation 
of cytokines from this cellular model. Fisette, et al., have demonstrated that challenge 
of epithelial cells with purified H.8 antigen elicited IL-8 and IL-6 in a TLR2-


























Figure 19: Schematic diagram summarizing the observed interactions of 
F62ΔlgtD and F62ΔlgtDH.8- with human monocytes and macrophages. 
Strain F62ΔlgtD and F62ΔlgtDH.8- were observed to elicit similar levels of cytokines 
from human monocytes. However, during challenge of human macrophages, strain 
F62ΔlgtDH.8- was more likely to form large aggregates over time, upon contact with 
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explained by the use of a different model, but also by the fact that the epithelial cells 
were challenged with dilutions of purified antigen. It is possible that the challenge 
concentration of H.8 over-represents the amount found on the bacterial cell surface 
during natural infection. Additionally, use of purified H.8 is prone to contamination 
by outer membrane components (88). Finally, the presentation of cell surface antigens 
to immune cells may be altered when purified molecules are used rather than whole-
cell bacterial deletion mutants.     
 Upon examination of the physical interactions of the H.8- mutant and human 
macrophages, I found a marked difference in bacterial cell aggregation. Upon 
examination of macrophages in contact with large numbers of gonococci 
(approximately 70% of the total population), a greater percentage of the H.8- bacteria 
were observed to form large aggregates in comparison with the parent strain. Analysis 
of cell-cell interactions over time demonstrated that both parent strain and H.8- 
mutant were initially arranged in diplococci. Over time, the mutant bacteria appeared 
to form aggregates or microcolonies as they interacted with the human cells. This 
indicates that elimination of H.8 from the gonococcal cell surface does not simply 
cause a difference in surface charge, leading to increased aggregation of the bacteria 
in general. Cross-sectional analysis revealed that macrophages interacting with large 
bacterial aggregates did not contain large numbers of evenly distributed bacteria (as 
seen with the parent strain). In fact, analysis of several cells demonstrated that the 
macrophages in contact with large aggregates did not appear able to take up the 
bacteria efficiently. Historically, aggregation of N. gonorrhoeae has been shown to 




the bacteria used in this study were all opa- and pil+. Additionally, there exist no 
studies of gonococcal aggregation upon initial contact with macrophages.  
Though the mechanism behind the observed gonococcal aggregation is 
unknown, these data imply that the H.8 antigen may serve as an important PAMP 
during recognition by host macrophages. However, since H.8 is well-conserved 
among the neisserial pathogens, this molecule must in some way contribute to 
pathogenesis of the bacterium.  
The process of gonococcal phagocytosis has been studied, but the occurrence 
of intracellular survival by gonococci remains controversial. Reports differ based 
upon bacterial characteristics, experimental conditions, and cellular models (146-
153). Some studies have demonstrated that human monocytes/ macrophages are 
capable of efficiently killing gonococci in vitro (154, 155). However, other reports 
indicate both gonococcal resistance to phagocytosis and intracellular survival through 
use of a human blood model (156-158). More recent studies intended to characterize 
gonococcal virulence factors have also implicated gonococcal intracellular survival. 
Recently, a macrophage infectivity potentiator (MIP) has been described and 
characterized. This lipoprotein (Ng-MIP) was shown to promote the intracellular 
survival of N. gonorrhoeae in human macrophages (159). It has also been 
demonstrated that gonococcal IgA protease cleaves the lysosome/late endosome-
associated membrane protein-1 (lamp-1). Since gonococci have been detected in 
lamp-1-positive vacuoles after uptake by phagocytes and epithelial cells, secretion of 
IgA protease may significantly contribute to gonococcal escape of the phagosome and 




shown to arrest phagosome maturation within macrophages and inhibits the release of 
reactive oxygen species within human peripheral blood neutrophils and monocytes 
(161, 162). In the context of these findings, I hypothesize that the H.8 antigen has a 
role in increasing the efficiency of phagocytosis by human macrophages and may also 
contribute to intracellular survival.  
In future studies, it will be necessary to use additional staining procedures to 
more definitively examine intracellular vs. extracellular gonococci. In addition, it 
would be interesting to use our human macrophage model to study intracellular 
survival of H.8- gonococci in comparison with the parent strain. Analysis of the 
interactions of the H.8- strain with other cell types, such as human neutrophils, would 
also be important, as these cells are commonly observed in association with 




Chapter 3: TNFα-independent IL-8 Expression: Alterations in 





While it is known that some Gram-negative pathogens such as Salmonella 
spp. are able to establish infections via an extremely low inoculum (163), the 
infectious dose for N. gonorrhoeae is unknown and likely differs depending upon 
host gender and the site of colonization. Schneider, et al. demonstrated that an initial 
inoculum of only 250 gonococci was sufficient to establish infection in 3 of 7 healthy 
male volunteers in a clinical challenge (164). The best estimates of the number of 
bacteria transferred to women suggest an inoculating dose for women ranging from 
approximately 2 x 104  to 6 x 106 gonococci (165). Though data are limited to male 
clinical trials and tissue culture models of infection, it is probable that even given a 
high inoculating dose, only a very small number of gonococci will successfully 
invade the reproductive tract. 
 During infection, the degree of inflammation usually reflects disease severity 
and symptoms, and serves to clear the host of infectious microbes. Mucosal 
inflammation can occur as a result of the direct interaction of a pathogen with surface 
epithelial cells or with specific immune cells beneath the epithelial layer. The 




human innate response to bacterial infections. The cytokines produced as a result of 
infection can have both local and systemic effects including alteration of vascular 
permeability, recruitment of immune cells, accumulation of toxins, and tissue damage 
(36). Inflammation is widely accepted as the classic host response to gonococcal 
colonization; however the intricacies of the human immune response to this 
bacterium are unknown. In the following study, I chose to measure the production of 
several proinflammatory cytokines such as TNFα and IL-1β, as well as chemokines 
such as IL-8. These cytokines are associated respectively, with gonococci-induced 
tissue damage/inflammation and neutrophil/monocyte influx to the site of infection. 
I have hypothesized that in naturally occurring gonococcal infections, 
colonization and subsequent invasion by a small number of bacteria can result in a 
dramatic innate immune response. I show here that N. gonorrhoeae is remarkably 
efficient at eliciting significant levels of IL-8 in our low dose challenge model, in the 
absence of TNFα. The following data indicate that this IL-8 production is likely 
caused by direct contact of gonococcal surface molecules with monocytes and is NF-
κB-dependent. In addition, the data demonstrate that the MAP kinase JNK is not 
activated in the low dose model. These results demonstrate the importance of 
chemokines in gonococcal infection and imply that lowering the initial bacterial dose 
causes a striking per cell increase in the production of specific chemokines/cytokines. 
I propose a mechanism where a low dose challenge results in diminished AP-1 
activity and TNFα production while overall IL-8 levels remain constant.  
 






Challenge dose of N. gonorrhoeae affects cytokine production by monocytes. Primary 
human monocytes were challenged with a range of gonococcal doses and the 
production of several cytokines predicted to be important in gonococcal infections 
was measured. Gentamicin-killed bacteria were determined to be most appropriate for 
use in these experiments, removing the problems associated with gonococcal 
multiplication in the invasion media, and preventing phase variation of the challenge 
inoculum. In positive control samples (MOI = 10), TNFα, IL-1β, and IL-8 were all 
measurable in large quantities at 18 hours post infection (Figure 20A). In the low 
dose challenge (one bacterium per ten monocytes), approximately 20 ng/ml IL-8 was 
measurable, while the other cytokines tested were produced at very low levels or were 
immeasurable (Figure 20B). The difference in IL-8 production between the positive 
control and the low dose challenge was statistically insignificant, while TNFα and IL-
1β respectively resulted in a 20-fold and 10-fold reduction subsequent to low dose 
challenge (Figure 20C). These data indicate that during a low inoculum gonococcal 
challenge, large amounts of IL-8 are produced by human monocytes. This occurs in 
the absence of significant TNFα, demonstrating that the initial infectious dose can 
greatly impact the overall host cytokine profile. I next examined whether a similar 
dose-dependent differential for TNFα would result from monocytes challenged with 
either killed E. coli or killed S. typhimurium. The average fold reduction in TNFα 
between doses was shown to be significant for E. coli samples, yet insignificant for S. 




Figure 20: Production of cytokines by primary human monocytes after in vitro 
challenge.  
Cytokine profile of monocytes (106 per sample) after an 18-hr challenge with killed 
N. gonorrhoeae, strain F62ΔlgtD. Shown are TNFα, IL-1β and IL-8 levels as 
measured by ELISA. Data is representative of at least three independent experiments, 
each performed in triplicate. Error bars represent the standard error of the mean. 
Challenge with media alone resulted in no detectable TNFα or IL-1β, and 
approximately 1 ng/ml IL-8 (SEM= 0.8 ng/ml). (A) MOI = 10; positive control 
samples (B) MOI = 0.1; low dose challenge samples. (C) Statistical analysis of 
positive control and low dose samples using a paired, two-tailed, t test with a 95% 
confidence interval indicates that low dose inoculations resulted in significantly lower 
levels of TNFα (10-fold) and IL-1β (20-fold), but not IL-8 (2-fold). Asterisks (*) 
denote a statistically significant difference between doses: P < 0.05. (D) Statistical 
analysis of positive control and low dose challenges using E. coli or S. typhimurium 
in comparision to N. gonorrhoeae. Results of a paired, two-tailed, t test with a 95% 
confidence interval demonstrate that low dose inoculations resulted in significantly 
lower levels of TNFα for E. coli (as for N. gonorrhoeae) but not S. typhimurium. 
























differences in IL-8 production were observed between doses for either species (data 
not shown). These data may indicate that that the cytokine differential I observed for 
N. gonorrhoeae is species-specific. Experiments using live gonococci, where 
gentamicin (100 μg/ml) was added at 30 min post challenge, resulted in a slight 
increase in production of TNFα when compared with challenge by killed gonococci 
(data not shown). I attribute this difference to growth of the bacteria, as complete 
killing of the gonococci under these conditions did not occur in less than two hrs. 
These experiments revealed no significant difference in the production of IL-8 (data 
not shown). Since the concentration of IL-8 in these samples was quite high at both 
doses, it is logical that bacterial growth during gentamicin treatment did not result in 
significantly different IL-8 levels during live bacterial challenge. In addition, when 
monocytes were challenged with sonicated bacteria (MOI = 10 and MOI = 0.1), no 
significant differences in TNFα or IL-8 production were observed when compared 
with killed bacterial challenge samples (data not shown). I attribute this observation 
to the fact that gonococci routinely shed membrane blebs (containing DNA) and may 
not elicit alternate signaling patterns when lysed (167).  
In order to determine if the low inoculum was simply resulting in slower 
kinetics of cytokine production, I measured cytokine levels produced over time 
(Figure 21). In positive control samples, all three cytokines tested were detectable at 2 
hours post challenge. TNFα and IL-1β both increased over time until reaching a 
maximal level at about 6-12 hours post challenge. IL-8 expression continued to 
increase throughout the entire time course. During the low dose challenge (MOI = 
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Figure 21: Cytokine production by primary human monocytes over time. 
Monocytes (106 per sample) were challenged with killed N. gonorrhoeae, strain 
F62ΔlgtD. In the positive control challenge time course an MOI of 10 was used. All 
three cytokines tested were measurable during the entire time course. In the low dose 
time course an MOI of 0.1 was used. These experiments were performed twice in 




respectively) and when measurable, peaked at very low levels. TNFα and IL-1β 
measured after a longer time period (24 hrs) never approached levels seen in the 
positive control (data not shown), demonstrating that the low inoculum challenge did 
not affect cytokine kinetics. As in the positive control, IL-8 continued to increase 
during the time course at levels far above the other cytokines measured. In addition, 
since the low dose challenge results in the production of IL-8 in the absence of 
measurable TNFα, it suggests that IL-8 is not produced as a result of primary 
production of TNFα.  
 
IL-8 production is independent of TNFα and IL-1β. Since IL-8 production is often 
attributed to prior production of TNFα and IL-1β during bacterial infections, I tested 
whether small amounts of these cytokines in culture supernatants were driving 
production of IL-8 during low dose gonococcal infections. Primary cultures of human 
monocytes were pretreated with neutralizing antibodies against TNFα and IL-1β (the 
antibody concentration was experimentally shown to neutralize all of the TNFα or 
IL-1β in culture supernatants), and challenged with either an MOI of 10 (positive 
control) or a low MOI of 0.1. Resulting IL-8 production was measured by ELISA 
(Figure 22). Pretreatment of monocytes with the two antibodies had no effect on the 
amount of IL-8 expressed at each dose. These data indicate that IL-8 production by 
monocytes challenged with N. gonorrhoeae is likely a result of direct stimulation by a 











Figure 22: Cytokine production by challenged primary human monocytes after 
pretreatment with neutralizing antibodies. 
Monocytes (106 per sample) were pretreated with neutralizing antibodies for thirty 
mins prior to challenge with killed N. gonorrhoeae, strain F62ΔlgtD. Monocytes were 
challenged with an MOI equal to either 10 or 0.1. (A) IL-8 measurement at 18 hrs 
post challenge (in the presence of antibody able to neutralize all available TNFα). (B) 
IL-8 measurement at 18 hrs post challenge (in the presence of antibody able to 
neutralize all available IL-1β). Data represent the average of at least two independent 
experiments, each performed in triplicate. Error bars represent the standard deviation 





NF-κB Activation is Proportional to the Bacterial Challenge Dose.  The TNFα, IL-
1β, and IL-8 genes can all be transcriptionally regulated via NF-κB binding to 
specific DNA sequences within their promoters (168-170). However the importance 
of NF-κB in IL-8 expression is controversial (170-174). I hypothesized that NF-κB 
may not be activated during the low dose challenge. In order to test this hypothesis, 
primary human monocytes were differentiated into macrophages and challenged with 
different doses of gonococci (MOI = 10 and MOI = 0.1). Immunofluorescence 
staining and laser scanning confocal microscopy were employed to visualize the 
degree of NF-κBp65 translocation into macrophage nuclei. Random fields at each 
time point and dose were examined. At least fifty cells from each sample were 
analyzed and categorized as positive or negative for activated NF-κB staining in their 
nuclei (Figure 23A). The positive control challenge (MOI = 10) resulted in NF-κB 
activation in nearly 100% of the macrophages by 90 min. post challenge. In the low 
dose challenge (MOI = 0.1) at 90 min., NF-κB was translocated to the nucleus in 
approximately 12% of the macrophage population. At 120 min. post infection this 
percentage did not change significantly (Figure 23B). The percentage of activated 
cells in the low dose is reflective of the 10% of the macrophage population expected 
to come into direct contact with bacteria. NF-κB activation therefore, appears to 
result from direct contact between macrophages and gonococci. These data 
demonstrate that NF-κB is translocated into macrophage nuclei in low dose 
challenges and that the activated cell population is limited by the initial dose of 
infection. Based on these findings, it is likely that NF-κB is driving at least a portion 










Figure 23: Analysis of challenged primary human macrophages by confocal 
microscopy. 
Differentiated macrophages were challenged with killed N. gonorrhoeae, strain 
F62ΔlgtD, over time. Macrophages were challenged with an MOI of either 10 or 0.1, 
stained, and analyzed via confocal microscopy. Staining included phalloidin (red), 
SYTO-13 nucleic acid stain, and anti-NF-κBp65 (purple). Red shows cellular actin 
(lower left), green shows nuclear material (upper right), and purple shows activated 
NF-κBp65 (upper left). An overlay of the three colors is shown in the lower right 
panel. At least fifty cells per time point were analyzed and placed into one of two 
categories: those with NF-κBp65 in the nucleus and those without. (A) Confocal 
images showing unstimulated (- control) and activated (+ control) macrophage 
controls. (B) The percentage of cells with NF-κBp65 in the nucleus at 30, 60, 90, and 
120 mins post challenge for each MOI. Data shown represent the average of at least 





that the low dose challenge results in a marked increase in IL-8 production on a per 
cell basis. 
 
Effects of the NF-κB Inhibitor TPCK on IL-8 Production. In order to directly test the 
effects of NF-κB translocation on production of IL-8, I pretreated monocytes with 
TPCK, a chemical that blocks the activation of NF-κB by blocking phosphorylation 
and therefore subsequent degradation of IκB. Primary human monocytes were 
pretreated with TPCK over a dose range for 45 min. prior to challenge with 
gonococci. A positive control challenge (MOI = 10) was compared with the low dose 
challenge (MOI = 0.1) and supernatants were collected for cytokine ELISA analysis 
(Figure 24). This concentration of inhibitor was able to inhibit ~ 80 % of the IL-8 
produced in both low dose and positive control samples. TNFα production was 
completely inhibited by TPCK pretreatment (data not shown), as has been 
demonstrated previously (175, 176). These experiments demonstrate that inhibition of 
NF-κB almost completely inhibits the IL-8 production resulting from gonococcal 
challenge. Therefore, NF-κB is critical for the production of IL-8 during a gonococcal 
infection. 
 
Phosphorylated JNK is Undetectable in Low Dose Infections. AP-1 is a collective 
term which refers to a family of transcription factors. AP-1 exists as a dimer and is 
comprised of proteins from the Jun, Fos, Maf, and ATF sub-families. These 
molecules contribute to the regulation of many cytokine genes, including IL-8 and 









Figure 24: Inhibition of cytokine expression by TPCK. 
IL-8 measured after TPCK pretreatment of primary human monocytes challenged for 
18 hrs with killed N. gonorrhoeae, strain F62ΔlgtD. TPCK is a serine protease 
inhibitor that has been shown to block LPS- or cytokine-mediated activation of NF-
κB. Positive control samples were challenged with an MOI of 10, while low dose 
samples were challenged with an MOI of 0.1. Data shown are from one experiment 
performed in triplicate and are representative of three independent experiments. Error 





MAP kinases [for review see (179, 180)]. Since N. gonorrhoeae has been shown to 
activate AP-1 in an epithelial cell tissue culture model through activation of JNK 
(110), I chose to examine the roles of this and other MAP kinases in our low dose 
monocyte model of infection. I hypothesized that differential MAP kinase regulation 
may be responsible for our observed dose-dependent cytokine profile. I challenged 
monocytes with both low dose and positive control doses of gonococci for various 
lengths of time, collected lysates and analyzed the level of phosphorylation of several 
kinases by SDS-PAGE/western blotting experiments, using antibodies specific for 
phosphorylated p38, JNK, and ERK (Figure 25A). [Western blotting for this 
experiment was performed by Samuel Bish.] These data provide evidence that, unlike 
p38 and ERK, JNK is not phosphorylated in low dose challenge samples. 
[Overexposure of the JNK blot did not result in significant signal when compared 
with negative controls (data not shown)]. This indicates a dose-dependent difference 
in the MAP kinase signaling pathway. 
Three MAP kinase inhibitors were used to examine the roles of p38, ERK, 
and JNK in low dose challenge IL-8 production. The specificity of these inhibitors 
has been previously demonstrated (181-183). The data in Figure 25B show the 
percent inhibition of IL-8 after pretreatment with the inhibitors and subsequent 
bacterial challenge. The p38 inhibitor SB203580 inhibited most of the IL-8 
production, while the ERK inhibitor PD98059 inhibited about 30%. The JNK 
inhibitor SP600125 had almost no effect on IL-8 production. These data further 




Figure 25: Phosphorylation levels of MAP kinases from challenged primary 
human monocytes. 
Monocytes were challenged for the indicated time period with killed N. gonorrhoeae, 
strain F62ΔlgtD. (A) Resting monocytes (2 x 106 per sample) were challenged with an 
MOI of 10 or 0.1 over time. Monocyte whole cell lysates were collected and analyzed 
by immunoblot to detect the phosphorylation levels of p38 (f) ERK 1/2 (g), and JNK 
1/2/3 (h). (a) MOI = 0.1 (b) MOI = 10 (positive control) (c) untreated primary human 
monocytes (negative control) (d) LPS-treated monocytes (100 ng/ml) (e) mins, post-
challenge (f) probing monocyte lysates with phospho-p38 polyclonal antibody (g and 
h) same as f, except phospho-ERK and phospho-JNK, respectively (i) F-actin levels 
(loading control). Data are representative of three independent experiments. (B) 
Percent inhibition of IL-8 in low dose challenge samples after pretreatment with three 
specific MAP kinase inhibitors (PD98059/ ERK, SB203580/ p38, and SP600125/ 
JNK) and subsequent 18 hr challenge. These inhibitors were tested over a dose range 
and data shown are the result of the pretreatment of monocytes with 5 µM SB203580, 
50 µM SP600125, and 50 µM PD98059, thirty mins prior to bacterial challenge. 
Levels of inhibitors used were experimentally determined to have reached maximal 
inhibition (data not shown).   
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is not contributing significantly to IL-8 production resulting from the low dose 
challenge. 
  
Overall Cytokine Profile is Altered Depending upon the Initial Challenge Dose. In 
order to gain a greater understanding of overall gonococcal-induced dose-dependent 
cytokine expression, I employed a cytokine expression array. Monocytes were 
challenged with a specific dose of gonococci, incubated for 18 hrs, and supernatants 
were collected for array analysis (Figure 26). Several cytokines demonstrated dose-
dependent differences in expression (two-fold change or greater, see Table 1). 
Included in this group were TNFα, IL-1β, and IL-10. This correlates with previous 
ELISA data where TNFα, IL-1β, and IL-10 were all upregulated as a result of the 
higher challenge dose. Similar to IL-8, the cytokines IL-6, GRO, and MCP-1 were 
also substantially upregulated compared to negative control samples, yet did not 
differ significantly between doses. Interestingly, the chemokine epithelial neutrophil-
activating protein-1 (ENA-78) was measured to have a negative fold change. In other 
words, the low dose challenge resulted in greater production of this chemokine than 
did the high dose challenge. (No ENA-78 was measurable in unchallenged samples.) 
This finding demonstrates that a chemokine can be elicited specifically upon 
challenge with a low bacterial inoculum and not upon challenge with a higher 
inoculum. This phenomenon has never been reported, presumably since most in vitro 
experiments typically utilize higher challenge doses than those employed here. ENA-
78 is similar to IL-8 in structure and function, and may have significant disease 







Figure 26: Comparison of cytokine levels from both low dose and positive 
control inoculations during one experiment. 
Primary human monocytes were challenged for 18hrs with killed N. gonorrhoeae, 
strain F62ΔlgtD. Monocytes were challenged with an MOI of either 10 or 0.1. 
Densitometric analysis was carried out using a Gel Doc 2000 camera and Quantity 
One Software (BioRad Laboratories, Inc.). Internal positive controls were compared 
among array exposures and the means were found to be statistically similar (P= 
0.7548 according to a paired, two-tailed t test) prior to cross comparison of sample 










 Average fold change 
between doses 
TNFα + 5.3 
IL-1β + 8.6 
IL-10 + 17.5 
IL-8 + 1.8 
IL-6 + 1.0 
GRO + 1.0 
MCP-1 + 1.8 
ENA-78 - 2.9 
 
Table 1: Average fold change between doses.   
Table values represent an average of two independent array experiments. Bold 





 publication as further study is necessary to determine the significance of this 
chemokine during gonococcal challenge.) Taken together, these data indicate that the 
lower bacterial challenge elicits a dramatic immune response and that significant 
differences in the overall cytokine expression profile can result from two different 






Bacterial infections typically result in the production of specific pro-
inflammatory cytokines and chemokines, leading to clearance of the invading 
microbes. In this study, I have shown that when confronted with a low challenge dose 
of N. gonorrhoeae, human monocytes are extremely efficient producers of IL-8 as 
well as several other chemokines/cytokines. In this scenario, host cells do not produce 
significant levels of TNFα. This overall cytokine profile could result in an influx of 
neutrophils and monocytes to the site of colonization, without causing the pain 
associated with symptomatic infection. I therefore propose that a low percentage of 
invasive bacteria can elicit a dramatic innate immune response without causing 
substantial cytokine-mediated tissue damage .  
Cytokine response to N. gonorrhoeae has been investigated by several groups, 
but never in the context of a low dose infection (MOI = 0.1). The monocytic 
inflammatory response to a low dose gonococcal challenge has not been documented, 
though this dose is almost certainly physiologically relevant. Subsequent to this low 
dose challenge, I measured levels of IL-8 that were statistically similar to those of 
high dose challenge samples, yet were produced in the absence of significant amounts 
of TNFα. In addition, this work supports the conclusion that IL-8 production does not 
result from autocrine action by IL-1β. Makepeace, et al inoculated primary 
monocyte-derived human macrophages with N. gonorrhoeae at an MOI of 400 and  





























Figure 27: Schematic diagram summarizing the proposed model for the 
signaling differential induced by a low gonococcal MOI. 
Upon challenge with a low MOI vs. the positive control MOI, phosphorylated JNK 
was not detectable in low dose challenge samples. In addition, TNFα production was 
only observed upon challenge with the positive control MOI, where IL-8 was 
measurable upon challenge with both doses. I propose a mechanism by which AP-1 
dimers are not available to drive production of TNFα in low dose challenge samples, 























 IL-8 was observed when compared with controls, though negative control samples 
produced 10 ng/ml IL-8. Additionally, no IL-1β was detected from challenged 
samples within these experiments (136). Though these findings seem to be at odds 
with my results, the challenge dose that they employed greatly exceeded my high 
dose challenge. Therefore these results further support my observation of dose-
dependent alterations in cytokine gene expression. Analysis of two other bacterial 
species (E. coli and S. typhimurium) indicates that the dose differential we observed 
for N. gonorrhoeae may be species-specific, indicating an interesting avenue for 
future study.    
Through the use of neutralizing antibodies against TNFα and IL-1β (two of 
the strongest activators of IL-8) (172), I verified that the IL-8 measured was not being 
produced in response to either of these cytokines. I hypothesize that IL-8 production 
results from a direct interaction between a bacterial structure or product, with host 
monocytes. Lorenzen et al. have shown that Neisserial immunoglobulin (Ig)A1-
specific serine protease plays a role in eliciting IL-8 from peripheral blood 
mononuclear cells (185). In addition, recombinant Neisserial PorA has been shown to 
elicit several pro-inflammatory cytokines including IL-8. The Neisserial surface 
lipoprotein Lip has also been shown to elicit IL-8 and IL-6 in an immortalized 
epithelial model (111). Though LPS/ LOS activation is known to cause IL-8 
production from human monocytes(186), Pridmore, et al. demonstrated that both wild 
type and lpxA mutant (LOS deficient) meningococci were similarly able to induce IL-
8 promoter activity (131). Similarly, pili, LOS and gonococcal outer membrane 




macrophage model (136). A conflicting study showed that piliated gonococci were 
associated with increased production of IL-8 in an ex vivo human endometrial cell 
model (187). Recently, peptidoglycan has been shown to interact with mannose 
binding lectin, ultimately resulting in an increase in chemokine production and a 
decrease in TNFα production by macrophages (188). Specific gonococcal LOS 
molecules have also been shown to avidly bind mannose binding lectin in vitro (189). 
It is possible that one or a combination of several gonococcal surface components 
may be responsible for the cytokine differential we have observed in low dose 
challenge samples.  
It is known that IL-8 gene expression is affected by the binding of NF-κB, 
AP-1, and C/EBP (NF-IL-6) to regions of its promoter [for review see (174)]. The 
role that each of these transcription factors plays in the overall expression of IL-8 
remains unclear. TNFα gene expression is even more complex and varies among 
different cell types. In human monocytes, transcription factor binding sites for NF-
κB, AP-1 (Jun-ATF-2), Sp1, Egr-1, NFAT, and Ets/Elk have been identified in the 
TNFα promoter (178, 190-192). Interestingly, distinct stimuli (viral antigen, a 
calcium ionophore, Mycobacterium tuberculosis, and LPS) have been shown to result 
in the binding of different sets of transcriptional activators to shared binding sites in 
the TNFα promoter, in a cell-type specific manner (191-193). Specific combinations 
of these regulatory elements are required for recruitment of the coactivator proteins 
CBP/p300 and subsequent enhanceosome formation (190-192). Though NF-κB 
binding motifs have also been identified in the upstream regions flanking the TNFα 




these sequences produces little effect on TNFα induction by several distinct stimuli 
(191, 192). However, simultaneous mutations in each of the NF-κB sites of the mouse 
TNF promoter resulted in a 90% reduction in promoter response to LPS (194). These 
differences may be stimulus-specific or reflective of differences among cellular 
models.  
While NF-κB was historically thought to be essential for IL-8 expression in 
many cell types (170) NF-κB–independent IL-8 expression has been reported (171-
174). The confocal microscopy data shown here (Figure 23) demonstrate that NF-
κBp65 is translocated into the nucleus in low inoculum samples, though activation is 
limited by the initial dose. Though differentiated cells certainly have some altered 
sensitivity in comparison with monocytes, the NF-κB data generated from use of this 
model was reflective of the percentage of macrophages expected to come into direct 
contact with bacteria. These percentages correlate well with the cytokine differential 
observed in Figure 20 where monocyte cytokine production was measured. These 
data support the hypothesis that NF-κB activation and IL-8 production in the low 
dose are the result of direct contact between bacteria and macrophages. Inhibition of 
NF-κB translocation through use of the serine protease inhibitor TPCK significantly 
inhibited IL-8 expression. This indicates the importance of NF-κB in our model of 
gonococcal disease. 
AP-1 has clearly been shown to contribute to both TNFα and IL-8 expression. 
Since AP-1 abundance, binding, and activity are impacted by the activity of various 
MAP kinases, I examined the roles of ERK, JNK, and p38 in our low dose challenge 




the JNK pathway is not activated. Therefore, available c-Jun cannot be 
phosphorylated, which leads to a failure in further c-jun induction [for review see 
(180)]. Since c-Jun is a central component of all AP-1 complexes (179), the data 
suggest that in my model, AP-1 dimers are not available to bind to the DNA. The 
protein ATF2 is also phosphorylated in part by JNK (195). Thus in my model, fewer 
phosphorylated ATF2 proteins are available. Since AP-1 dimers (Jun-ATF-2) are 
important for enhanceosome formation and efficient transcription of the TNFα gene, 
it is not surprising that in the absence of phosphorylated c-jun, and with little 
available phosphorylated ATF-2, TNFα production is limited. I hypothesize that the 
IL-8 produced as result of the low dose gonococcal infection is mediated by NF-κB 
binding, independent of AP-1. In support of this, the AP-1 binding site has been 
shown to be dispensable for IL-8 production in some studies (196, 197). Similarly, 
differential transcription of cytokine genes has been demonstrated in the IL-1β 
promoter, where fibronectin was shown to induce AP-1 binding, but not NF-κB 
(198). Additionally, different TLR agonists have been shown to elicit distinct 
cytokine responses (i.e. induction of TNFα but not IL-1β) though both AP-1 and NF-
κB were activated (199). I believe that in response to a low dose challenge, the TNFα 
promoter is not efficiently transcribed. Though the NF-κB inhibitor TPCK resulted in 
complete inhibition of TNFα production, I feel that this is due to TPCK-induced 
inhibition of TNFα mRNA expression. This effect by TPCK has been previously 
documented in a model of LPS-stimulated macrophages (175, 176).    
The results of my cytokine array experiment provide further insight into the 




Several cytokines and chemokines were upregulated (in both low and high dose 
challenge samples) when compared to untreated controls, and the dose differential 
was apparent for TNFα, IL-1β, and IL-10 (Fig 7). Both the chemokines GRO and 
MCP-1 were shown to be produced in large quantities when compared to negative 
controls. Interestingly, their production, just as that of IL-8, was not significantly 
altered in the low dose challenge. Since both GRO and MCP-1 are also 
transcriptionally regulated in part by NF-κβ it is possible that these genes are still 
efficiently transcribed, as is IL-8, without the presence of AP-1 (200-202). Since 
chemokine regulation is critical for appropriate regulation of leukocyte infiltration, it 
is also essential for regulation of the intensity of the inflammatory response. In the 
context of the low dose, one could imagine an asymptomatic gonococcal infection 
where a significant chemokine response is generated in the absence of substantial 
TNFα production. This would result in continued bacterial transmission and gradual 
microbial clearance without the host experiencing noticeable symptoms. These 
experiments also demonstrated greater elicitation of the chemokine ENA-78 
subsequent to low dose challenges when compared to positive controls. As this 
chemokine causes neutrophil influx and activation, similar to IL-8, it may have a 
significant impact during gonococcal infection (184).   
I further propose that gonococci in different doses can appear as distinct 
stimuli to host monocytes. When gonococci exist in sufficient numbers, multicellular 
aggregates form. These aggregates may physically alter the scope of the interaction 
between gonococcal PAMPs such as Por, Lip, and LOS, and their corresponding 




host cells may occur, in comparison with that of individual diplococci. In the future, it 
would be interesting to determine which gonococcal surface molecules contribute to 
the observed signaling differential.  
Taken together the results of this study indicate that N. gonorrhoeae is 
remarkably efficient at inducing the production of several cytokines/chemokines from 
host monocytes. This response can occur in the absence of damaging cytokines 
(TNFα) and appears to result from direct gonococcal/monocyte surface contact in an 
NF-κB-dependent manner. This observation may help to explain gonococcal disease 
in women, which is so often asymptomatic. While these studies are helpful in 
understanding gonococcal pathogenesis, I also feel that the implications are broadly 








Chapter 4: Conclusions 
 
 Neisseria gonorrhoeae is an obligate pathogen which has an important global 
impact on human health. Significant disease sequelae can result from infection by N. 
gonorrhoeae, including PID in women, which often results in sterility. A correlation 
between gonococcal infection and increased transmission of HIV also contributes to 
the need for greater understanding of gonococcal pathogenesis. This organism 
achieves colonization and invasion through a multi-step process, presumably 
involving many types of host cells. Inflammation and neutrophil influx are two 
important diagnostic symptoms of gonorrhea, and there is very little antibody 
response generated against this bacterium. Diagnosis of gonorrhea is complicated by 
many factors including the large percentage of asymptomatic infections in women. 
The experiments described herein relate to two important gonococcal surface 
molecules, LOS and H.8, and highlight the importance of bacterial dose upon disease 
outcome.  
In order to analyze the impact of antigenic variation in gonococcal LOS, I 
utilized gonococcal mutants with specific LOS structures to challenge human 
monocytes. These mutants expressed LOS structures associated with either 
symptomatic (F62/ F62ΔlgtD) or asymptomatic (F62ΔlgtA) infection. These specific 
LOS structures have been previously shown to affect gonococcal interaction with 
epithlelial cell models (61). Upon challenge of monocytes during this study, the levels 
of several proinflammatory cytokines were measured. The data generated 




the production of these cytokines. From my data, as well as several other reports, it 
seems likely that differences in the immunostimulatory potential of LOS variants 
during interactions with human monocytes may stem from alterations in the structure 
of lipid A (113, 133-135). In addition, whole-cell bacterial challenge was shown to be 
much more stimulatory than challenge with purified LOS. This implies that other 
surface structures may play an important role with regard to cytokine elicitation. 
Sialylation of LOS was shown to result in upregulation of the chemokine MCP-2 
from challenged cells. As MCP-2 is associated with recruitment of monocytes, this 
finding may indicate a role for sialylation during further interactions with this cell 
type. A greater understanding of the mechanism behind MCP-2 elicitation by 
gonococci, as well as quantitation of this cytokine during challenge, will be important 
questions to explore in the future.  
Through use of an H.8- strain generated in our laboratory, I was able to 
directly compare the effects of this antigen on gonococcal interactions with human 
monocytes. Though I observed only insignificant differences in cytokine elicitation 
by H.8- mutants, this molecule appeared important during interactions with host 
macrophages. A greater percentage of mutant gonococci were shown to form large 
aggregates upon contact with host macrophages over time, in comparison with the 
parent strain. These bacterial aggregates also appeared to resist phagocytosis. As 
recent studies have implicated the ability of gonococci to survive within host immune 
cells, I hypothesize that H.8 antigen may serve as an important PAMP, thereby 





 After exploration of the effects of dose on gonococcal challenge, I have 
demonstrated a differential response by human monocytes. A low challenge dose of 
N. gonorrhoeae was demonstrated able to efficiently elicit a significant amount of IL-
8, as well as several other chemokines/cytokine. During this scenario, monocytes did 
not produce significant levels of TNFα, the cytokine associated with gonococci-
induced tissue damage. In addition, levels of the chemokine ENA-78 were measured 
to be approximately three-fold greater in the low dose challenge when compared with 
positive controls. I hypothesize that this overall cytokine profile could result in an 
influx of neutrophils and monocytes to the site of colonization, without causing the 
pain associated with symptomatic infection. I therefore propose that a low percentage 
of invasive bacteria can elicit a dramatic innate immune response without causing 
substantial cytokine-mediated tissue damage. 
 IL-8 induction was demonstrated to be NF-κB-dependent, though this 
activation was limited by the inoculating dose, implying that direct contact between 
bacteria and host cells is necessary for induction of this chemokine. Analysis of 
various MAP kinases indicated that low MOI challenges were able to efficiently 
activate both the ERK and p38 pathways but failed to activate the JNK pathway. A 
lack of phosphorylated JNK leads to decreased production of AP-1 dimers, 
transcription factors that are critical for efficient transcription of TNFα. I therefore 
hypothesize that a low MOI gonococcal challenge dose results in diminished AP-1 
activity and TNFα production while IL-8 levels remain constant. I further propose 
that gonococci in different doses can appear as distinct stimuli to host monocytes. 




physically alter the interaction between gonococcal PAMPS and their corresponding 
PRRs. In this way, distinct recognition and/or phagocytosis by host cells may occur, 
in comparison with that of individual diplococci. 
The data generated from these studies contribute to our current understanding 
of gonococcal pathogenesis and may have future importance in the development of 
successful gonococcal vaccines. My results highlight the importance of monocyte/ 
macrophage interactions with N. gonorrhoeae. In addition, the implication that 
bacterial dose can significantly alter disease outcome is broadly applicable to our 
understanding of the development of immune responses not only to infection by N. 
gonorrhoeae, but to all infectious microbes.  
 From the data presented in this dissertation and using data from the published 
literature, I would like to propose the following overall model of gonococcal infection 
(Figure 28). Since gonococci expressing invasive LOS structures (lacto-N-
neotetraose) are readily sialylated, I hypothesize that after initial colonization of host 
epithelial cells, these sialylated gonococci encounter monocytes and resident 
macrophages and elicit MCP-2 production. Elicitation of this chemokine contributes 
to the specific recruitment of additional host monocytes. In addition, only a portion of 
the initial gonococcal inoculum is able to transcytose the epithelial tissues. This small 
number of bacteria interacts with immune cells, leading to phosphorylation of ERK 
and p38 and NF-κB translocation, yet no phosphorylation of c-Jun. Therefore, a lack 
of AP-1 dimers exists and cytokine signaling (i.e. TNFα production) is limited. 
Though chemokine production is induced from this low MOI, TNFα levels are not 




structures (such as H.8) by infiltrating monocytes and neutrophils may allow efficient 
phagocytosis of these bacteria. Once distributed within immune cell vacuoles, the 
gonococci employ several virulence factors such as Ng-MIP, IgA protease, and porin 
to allow intracellular survival. This scenario could result in a persistent asymptomatic 








Figure 28: Proposed Model of Gonococcal Disease in Women. 
Schematic diagram illustrating several aspects of gonococcal disease in women. 
Shown are the three main stages of gonococcal infection (adherence, invasion, and 
transcytosis), a summary of the observed interactions between gonococci and human 
primary monocytes and macrophages (LOS sialylation with host CMP-NANA, NF-
κB activation, and cytokine/chemokine production), and proposed disease 
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